{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:54:21Z","timestamp":1761062061679,"version":"3.40.5"},"reference-count":417,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["R\/Dev\/IX-Sch. (SRF-JRF-CAS-Zoology)\/75159","Award Reference ID: 221610130980"],"award-info":[{"award-number":["R\/Dev\/IX-Sch. (SRF-JRF-CAS-Zoology)\/75159","Award Reference ID: 221610130980"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024586","name":"Human Resource Development Centre, Council of Scientific And Industrial Research","doi-asserted-by":"publisher","award":["09\/013(0772\/2018-EMR-I)"],"award-info":[{"award-number":["09\/013(0772\/2018-EMR-I)"]}],"id":[{"id":"10.13039\/501100024586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EEQ\/2022\/000688"],"award-info":[{"award-number":["EEQ\/2022\/000688"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IRIS ID-2021-13098"],"award-info":[{"award-number":["IRIS ID-2021-13098"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002742","name":"Banaras Hindu University","doi-asserted-by":"publisher","award":["Institute of Eminence"],"award-info":[{"award-number":["Institute of Eminence"]}],"id":[{"id":"10.13039\/501100002742","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04161-7","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T07:53:57Z","timestamp":1737964437000},"page":"359-386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Stress regulatory hormones and cancer: the contribution of epinephrine and cancer therapeutic value of beta blockers"],"prefix":"10.1007","volume":"88","author":[{"given":"Rajan Kumar","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiv Govind","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddharth","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"4161_CR1","unstructured":"C. Tsigos, I. Kyrou, E. Kassi, G.P. Chrousos, Stress: endocrine physiology and pathophysiology. In: Feingold K.R., Anawalt B., Blackman M.R., Boyce A., Chrousos G., Corpas E., et al., editors. Endotext. South Dartmouth (MA) 2000"},{"key":"4161_CR2","unstructured":"B. Chu, K. Marwaha, T. Sanvictores, D. Ayers, Physiology, Stress Reaction. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL), 2024). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK541120\/"},{"key":"4161_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev.physiol.67.040403.120816","volume":"67","author":"E Charmandari","year":"2005","unstructured":"E. Charmandari, C. Tsigos, G. Chrousos, Endocrinology of the stress response. Annu. Rev. Physiol. 67, 259\u2013284 (2005)","journal-title":"Annu. Rev. Physiol."},{"key":"4161_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.biopsycho.2016.01.015","volume":"117","author":"S Rotenberg","year":"2016","unstructured":"S. Rotenberg, J.J. McGrath, Inter-relation between autonomic and HPA axis activity in children and adolescents. Biol. Psychol. 117, 16\u201325 (2016)","journal-title":"Biol. Psychol."},{"key":"4161_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2020.601939","volume":"14","author":"JA Sheng","year":"2020","unstructured":"J.A. Sheng, N.J. Bales, S.A. Myers, A.I. Bautista, M. Roueinfar, T.M. Hale et al. The hypothalamic-pituitary-adrenal axis: development, programming actions of hormones, and maternal-fetal interactions. Front. Behav. Neurosci. 14, 601939 (2020)","journal-title":"Front. Behav. Neurosci."},{"key":"4161_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.yfrne.2018.03.004","volume":"49","author":"FS Dhabhar","year":"2018","unstructured":"F.S. Dhabhar, The short-term stress response - mother nature\u2019s mechanism for enhancing protection and performance under conditions of threat, challenge, and opportunity. Front. Neuroendocrinol. 49, 175\u2013192 (2018)","journal-title":"Front. Neuroendocrinol."},{"key":"4161_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fnbeh.2018.00127","volume":"12","author":"LD Godoy","year":"2018","unstructured":"L.D. Godoy, M.T. Rossignoli, P. Delfino-Pereira, N. Garcia-Cairasco, E.H. de Lima Umeoka, A comprehensive overview on stress neurobiology: basic concepts and clinical implications. Front. Behav. Neurosci. 12, 127 (2018)","journal-title":"Front. Behav. Neurosci."},{"issue":"2","key":"4161_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/j.2040-4603.2016.tb00694.x","volume":"6","author":"JP Herman","year":"2016","unstructured":"J.P. Herman, J.M. McKlveen, S. Ghosal, B. Kopp, A. Wulsin, R. Makinson et al. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr. Physiol. 6(2), 603\u2013621 (2016)","journal-title":"Compr. Physiol."},{"issue":"4","key":"4161_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","volume":"8","author":"SM Smith","year":"2006","unstructured":"S.M. Smith, W.W. Vale, The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin. Neurosci. 8(4), 383\u2013395 (2006)","journal-title":"Dialogues Clin. Neurosci."},{"key":"4161_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1146\/annurev.psych.093008.100321","volume":"61","author":"F Holsboer","year":"2010","unstructured":"F. Holsboer, M. Ising, Stress hormone regulation: biological role and translation into therapy. Annu. Rev. Psychol. 61, 81\u2013109 (2010)","journal-title":"Annu. Rev. Psychol."},{"issue":"1","key":"4161_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.psyneuen.2009.02.016","volume":"35","author":"JC Pruessner","year":"2010","unstructured":"J.C. Pruessner, K. Dedovic, M. Pruessner, C. Lord, C. Buss, L. Collins et al. Stress regulation in the central nervous system: evidence from structural and functional neuroimaging studies in human populations - 2008 Curt Richter award winner. Psychoneuroendocrinology 35(1), 179\u2013191 (2010)","journal-title":"Psychoneuroendocrinology"},{"key":"4161_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.738252","volume":"11","author":"H Hong","year":"2021","unstructured":"H. Hong, M. Ji, D. Lai, Chronic stress effects on tumor: pathway and mechanism. Front. Oncol. 11, 738252 (2021)","journal-title":"Front. Oncol."},{"issue":"3","key":"4161_CR13","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ccell.2024.01.013","volume":"42","author":"XY He","year":"2024","unstructured":"X.Y. He, Y. Gao, D. Ng, E. Michalopoulou, S. George, J.M. Adrover et al. Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment. Cancer Cell 42(3), 474\u201386.e12 (2024)","journal-title":"Cancer Cell"},{"issue":"11","key":"4161_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2030-2","volume":"10","author":"X Zhang","year":"2019","unstructured":"X. Zhang, Y. Zhang, Z. He, K. Yin, B. Li, L. Zhang et al. Chronic stress promotes gastric cancer progression and metastasis: an essential role for ADRB2. Cell Death Dis. 10(11), 788 (2019)","journal-title":"Cell Death Dis."},{"issue":"1","key":"4161_CR15","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.2004659","volume":"10","author":"J An","year":"2021","unstructured":"J. An, L. Feng, J. Ren, Y. Li, G. Li, C. Liu et al. Chronic stress promotes breast carcinoma metastasis by accumulating myeloid-derived suppressor cells through activating beta-adrenergic signaling. Oncoimmunology 10(1), 2004659 (2021)","journal-title":"Oncoimmunology"},{"issue":"2","key":"4161_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/jcp.25092","volume":"231","author":"C-C Chin","year":"2016","unstructured":"C.-C. Chin, J.-M. Li, K.-F. Lee, Y.-C. Huang, K.-C. Wang, H.-C. Lai et al. Selective \u03b22-AR blockage suppresses colorectal cancer growth through regulation of EGFR-Akt\/ERK1\/2 signaling, G1-phase arrest, and apoptosis. J. Cell. Physiol. 231(2), 459\u2013472 (2016)","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"4161_CR17","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41388-021-02170-0","volume":"41","author":"KY Fjaestad","year":"2022","unstructured":"K.Y. Fjaestad, A.M.A. Romer, V. Goitea, A.Z. Johansen, M.L. Thorseth, M. Carretta et al. Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment. Oncogene 41(9), 1364\u20131375 (2022)","journal-title":"Oncogene"},{"issue":"13","key":"4161_CR18","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202400725RR","volume":"38","author":"S Cavalu","year":"2024","unstructured":"S. Cavalu, S. Saber, A.E. Amer, R.S. Hamad, M.A. Abdel-Reheim, E.A. Elmorsy et al. The multifaceted role of beta-blockers in overcoming cancer progression and drug resistance: extending beyond cardiovascular disorders. FASEB J. 38(13), e23813 (2024)","journal-title":"FASEB J."},{"issue":"18","key":"4161_CR19","doi-asserted-by":"publisher","first-page":"9922","DOI":"10.3390\/ijerph18189922","volume":"18","author":"BA Franklin","year":"2021","unstructured":"B.A. Franklin, A. Rusia, C. Haskin-Popp, A. Tawney, Chronic stress, exercise and cardiovascular disease: placing the benefits and risks of physical activity into perspective. Int. J. Env. Res. Public. Health 18(18), 9922 (2021)","journal-title":"Int. J. Env. Res. Public. Health"},{"issue":"4","key":"4161_CR20","first-page":"9","volume":"15","author":"MR Salleh","year":"2008","unstructured":"M.R. Salleh, Life event, stress and illness. Malays. J. Med. Sci. 15(4), 9\u201318 (2008)","journal-title":"Malays. J. Med. Sci."},{"issue":"6","key":"4161_CR21","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nrcardio.2012.45","volume":"9","author":"A Steptoe","year":"2012","unstructured":"A. Steptoe, M. Kivimaki, Stress and cardiovascular disease. Nat. Rev. Cardiol. 9(6), 360\u2013370 (2012)","journal-title":"Nat. Rev. Cardiol."},{"issue":"18","key":"4161_CR22","doi-asserted-by":"publisher","first-page":"e6816","DOI":"10.1097\/MD.0000000000006816","volume":"96","author":"SN Assadi","year":"2017","unstructured":"S.N. Assadi, What are the effects of psychological stress and physical work on blood lipid profiles? Medicine 96(18), e6816 (2017)","journal-title":"Medicine"},{"issue":"1","key":"4161_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11906-009-0084-8","volume":"12","author":"TM Spruill","year":"2010","unstructured":"T.M. Spruill, Chronic psychosocial stress and hypertension. Curr. Hypertens. Rep. 12(1), 10\u201316 (2010)","journal-title":"Curr. Hypertens. Rep."},{"key":"4161_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2019.104501","volume":"111","author":"A Labanski","year":"2020","unstructured":"A. Labanski, J. Langhorst, H. Engler, S. Elsenbruch, Stress and the brain-gut axis in functional and chronic-inflammatory gastrointestinal diseases: a transdisciplinary challenge. Psychoneuroendocrinology 111, 104501 (2020)","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"4161_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.7178\/ig.1.1.6","volume":"1","author":"A Katsanos","year":"2012","unstructured":"A. Katsanos, S. Giannopoulos, G. Tsivgoulis, The brain-gut axis in the pathophysiology of irritable bowel syndrome. Immunogastroenterology 1(1), 23\u201326 (2012)","journal-title":"Immunogastroenterology"},{"issue":"6","key":"4161_CR26","first-page":"591","volume":"62","author":"PC Konturek","year":"2011","unstructured":"P.C. Konturek, T. Brzozowski, S.J. Konturek, Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J. Physiol. Pharmacol. 62(6), 591\u2013599 (2011)","journal-title":"J. Physiol. Pharmacol."},{"issue":"8","key":"4161_CR27","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.bbi.2007.03.009","volume":"21","author":"E Chen","year":"2007","unstructured":"E. Chen, G.E. Miller, Stress and inflammation in exacerbations of asthma. Brain Behav. Immun. 21(8), 993\u2013999 (2007)","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"4161_CR28","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/PSY.0b013e318199dbc3","volume":"71","author":"TJ Marin","year":"2009","unstructured":"T.J. Marin, E. Chen, J.A. Munch, G.E. Miller, Double-exposure to acute stress and chronic family stress is associated with immune changes in children with asthma. Psychosom. Med. 71(4), 378\u2013384 (2009)","journal-title":"Psychosom. Med."},{"issue":"1","key":"4161_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.iac.2010.09.009","volume":"31","author":"ND Dave","year":"2011","unstructured":"N.D. Dave, L. Xiang, K.E. Rehm, G.D. Marshall Jr., Stress and allergic diseases. Immunol. Allergy Clin. North. Am. 31(1), 55\u201368 (2011)","journal-title":"Immunol. Allergy Clin. North. Am."},{"issue":"1","key":"4161_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-017-0742-1","volume":"18","author":"MFP Peres","year":"2017","unstructured":"M.F.P. Peres, J.P.P. Mercante, P.R. Tobo, H. Kamei, M.E. Bigal, Anxiety and depression symptoms and migraine: a symptom-based approach research. J. Headache Pain. 18(1), 37 (2017)","journal-title":"J. Headache Pain."},{"issue":"1","key":"4161_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-0988-x","volume":"20","author":"T Dresler","year":"2019","unstructured":"T. Dresler, S. Caratozzolo, K. Guldolf, J.I. Huhn, C. Loiacono, T. Niiberg-Pikksoot et al. Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications. J. Headache Pain. 20(1), 51 (2019)","journal-title":"J. Headache Pain."},{"issue":"3","key":"4161_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4103\/0253-7176.162924","volume":"37","author":"SY Dholakia","year":"2015","unstructured":"S.Y. Dholakia, C. Susmita, K.D. Ranjit, Y. Singh, D. Braganza, Neurosis meets psychosis: case series from a tertiary care center in South India. Indian. J. Psychol. Med. 37(3), 360\u2013363 (2015)","journal-title":"Indian. J. Psychol. Med."},{"issue":"3","key":"4161_CR33","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.psc.2009.06.001","volume":"32","author":"AY Shalev","year":"2009","unstructured":"A.Y. Shalev, Posttraumatic stress disorder and stress-related disorders. Psychiatr. Clin. North. Am. 32(3), 687\u2013704 (2009)","journal-title":"Psychiatr. Clin. North. Am."},{"issue":"70","key":"4161_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4103\/1463-1741.134917","volume":"16","author":"B Wright","year":"2014","unstructured":"B. Wright, E. Peters, U. Ettinger, E. Kuipers, V. Kumari, Understanding noise stress-induced cognitive impairment in healthy adults and its implications for schizophrenia. Noise Health 16(70), 166\u2013176 (2014)","journal-title":"Noise Health"},{"key":"4161_CR35","doi-asserted-by":"publisher","unstructured":"T.G. Adams, B. Kelmendi, C.A. Brake, P. Gruner, C.I. Badour, C. Pittenger. The role of stress in the pathogenesis and maintenance of obsessive-compulsive disorder. Chronic Stress. 2. (2018). https:\/\/doi.org\/10.1177\/2470547018758043","DOI":"10.1177\/2470547018758043"},{"issue":"12","key":"4161_CR36","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1002\/acr.24085","volume":"72","author":"KJ Polinski","year":"2020","unstructured":"K.J. Polinski, E.A. Bemis, M. Feser, J. Seifert, M.K. Demoruelle, C.C. Striebich et al. Perceived stress and inflammatory arthritis: a prospective investigation in the studies of the etiologies of rheumatoid arthritis cohort. Arthritis Care Res. 72(12), 1766\u20131771 (2020)","journal-title":"Arthritis Care Res."},{"issue":"2","key":"4161_CR37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s13679-018-0306-y","volume":"7","author":"ES van der Valk","year":"2018","unstructured":"E.S. van der Valk, M. Savas, E.F.C. van Rossum, Stress and obesity: are there more susceptible individuals? Curr. Obes. Rep. 7(2), 193\u2013203 (2018)","journal-title":"Curr. Obes. Rep."},{"issue":"9","key":"4161_CR38","volume":"14","author":"K Sharma","year":"2022","unstructured":"K. Sharma, S. Akre, S. Chakole, M.B. Wanjari, Stress-induced diabetes: a review. Cureus 14(9), e29142 (2022)","journal-title":"Cureus"},{"issue":"3","key":"4161_CR39","first-page":"QC01","volume":"9","author":"S Nagma","year":"2015","unstructured":"S. Nagma, G. Kapoor, R. Bharti, A. Batra, A. Batra, A. Aggarwal et al. To evaluate the effect of perceived stress on menstrual function. J. Clin. Diagn. Res. 9(3), QC01\u2013QC03 (2015)","journal-title":"J. Clin. Diagn. Res."},{"key":"4161_CR40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.copsyc.2016.05.007","volume":"13","author":"MP McCabe","year":"2017","unstructured":"M.P. McCabe, C. Connaughton, Sexual dysfunction and relationship stress: how does this association vary for men and women? Curr. Opin. Psychol. 13, 81\u201384 (2017)","journal-title":"Curr. Opin. Psychol."},{"issue":"3","key":"4161_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2174\/1871528113666140522104422","volume":"13","author":"Y Chen","year":"2014","unstructured":"Y. Chen, J. Lyga, Brain-skin connection: stress, inflammation and skin aging. Inflamm. Allergy Drug. Targets 13(3), 177\u2013190 (2014)","journal-title":"Inflamm. Allergy Drug. Targets"},{"issue":"4","key":"4161_CR42","doi-asserted-by":"publisher","first-page":"e0175904","DOI":"10.1371\/journal.pone.0175904","volume":"12","author":"EMJ Peters","year":"2017","unstructured":"E.M.J. Peters, Y. Muller, W. Snaga, H. Fliege, A. Reisshauer, T. Schmidt-Rose et al. Hair and stress: a pilot study of hair and cytokine balance alteration in healthy young women under major exam stress. PLoS One 12(4), e0175904 (2017)","journal-title":"PLoS One"},{"issue":"3","key":"4161_CR43","first-page":"227","volume":"10","author":"J Reedy","year":"1975","unstructured":"J. Reedy, Galen on cancer and related diseases. Clio Med. 10(3), 227\u2013238 (1975)","journal-title":"Clio Med."},{"issue":"1","key":"4161_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.7150\/jca.10336","volume":"6","author":"A Di Lonardo","year":"2015","unstructured":"A. Di Lonardo, S. Nasi, S. Pulciani, Cancer: we should not forget the past. J. Cancer 6(1), 29\u201339 (2015)","journal-title":"J. Cancer"},{"issue":"1","key":"4161_CR45","first-page":"1","volume":"22","author":"L LeShan","year":"1959","unstructured":"L. LeShan, Psychological states as factors in the development of malignant disease: a critical review. J. Natl Cancer Inst. 22(1), 1\u201318 (1959)","journal-title":"J. Natl Cancer Inst."},{"key":"4161_CR46","unstructured":"Rosch, P. J. Stress and cancer: Disorders of communication, control, and civilization. In C. L. Cooper (Ed.), Handbook of stress, medicine, and health. CRC Press\/Routledge\/Taylor & Francis Group, (1996) pp. 27\u201360"},{"key":"4161_CR47","unstructured":"W.H. Walshe. The nature and treatment of cancer: Taylor and Walton, (1846)"},{"key":"4161_CR48","unstructured":"M. Deshaies-Gendron, Enquiries into the nature, knowledge, and cure of cancers. by Mr. Deshaies Gendron,\u2026 Done out\u2026 of French: Gale Ecco, (Print Editions, 2018)"},{"key":"4161_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577311","volume":"346","author":"B Mravec","year":"2020","unstructured":"B. Mravec, M. Tibensky, L. Horvathova, Stress and cancer. Part I: mechanisms mediating the effect of stressors on cancer. J. Neuroimmunol. 346, 577311 (2020)","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"4161_CR50","doi-asserted-by":"publisher","first-page":"6","DOI":"10.29046\/JJP.004.1.003","volume":"4","author":"MD Edelstein","year":"1986","unstructured":"MD. Edelstein, M. Bernard, The Stress Factor: Exploring the Possibility of a Psychological Component to Cancer. Jefferson J Psychiatry 4(1), 6 (1986). https:\/\/doi.org\/10.29046\/JJP.004.1.003","journal-title":"Jefferson J Psychiatry"},{"key":"4161_CR51","unstructured":"J. Paget, Lectures on surgical pathology delivered at the Royal College of Surgeons of England, London. (1863)"},{"key":"4161_CR52","unstructured":"A Treatise, Practical and Theoretic, on Cancers and the Cancer Process. Bristol Med Chir J. 12(44):128 (1894)"},{"key":"4161_CR53","doi-asserted-by":"publisher","unstructured":"Selye H. A syndrome produced by diverse nocuous agents. 1936. J Neuropsychiatry Clin Neurosci. Spring. 10(2):230\u2013231 (1998). https:\/\/doi.org\/10.1176\/jnp.10.2.230a","DOI":"10.1176\/jnp.10.2.230a"},{"key":"4161_CR54","unstructured":"Selye, H. The stress of life. McGraw-Hill, (1956)."},{"issue":"4201","key":"4161_CR55","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1126\/science.168638","volume":"189","author":"V Riley","year":"1975","unstructured":"V. Riley, Mouse mammary tumors: alteration of incidence as apparent function of stress. Science 189(4201), 465\u2013467 (1975)","journal-title":"Science"},{"key":"4161_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577312","volume":"346","author":"B Mravec","year":"2020","unstructured":"B. Mravec, M. Tibensky, L. Horvathova, Stress and cancer. Part II: therapeutic implications for oncology. J. Neuroimmunol. 346, 577312 (2020)","journal-title":"J. Neuroimmunol."},{"key":"4161_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1032294","volume":"13","author":"Y Liu","year":"2022","unstructured":"Y. Liu, S. Tian, B. Ning, T. Huang, Y. Li, Y. Wei, Stress and cancer: the mechanisms of immune dysregulation and management. Front. Immunol. 13, 1032294 (2022)","journal-title":"Front. Immunol."},{"issue":"3","key":"4161_CR58","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jpsychores.2008.11.002","volume":"66","author":"M Hamer","year":"2009","unstructured":"M. Hamer, Y. Chida, G.J. Molloy, Psychological distress and cancer mortality. J. Psychosom. Res. 66(3), 255\u2013258 (2009)","journal-title":"J. Psychosom. Res."},{"issue":"12","key":"4161_CR59","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41568-021-00395-5","volume":"21","author":"A Eckerling","year":"2021","unstructured":"A. Eckerling, I. Ricon-Becker, L. Sorski, E. Sandbank, S. Ben-Eliyahu, Stress and cancer: mechanisms, significance and future directions. Nat. Rev. Cancer 21(12), 767\u2013785 (2021)","journal-title":"Nat. Rev. Cancer"},{"key":"4161_CR60","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3389\/fonc.2020.01492","volume":"10","author":"S Dai","year":"2020","unstructured":"S. Dai, Y. Mo, Y. Wang, B. Xiang, Q. Liao, M. Zhou et al. Chronic stress promotes cancer development. Front. Oncol. 10, 1492 (2020)","journal-title":"Front. Oncol."},{"issue":"12","key":"4161_CR61","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S1470-2045(17)30677-0","volume":"18","author":"MM Fidler","year":"2017","unstructured":"M.M. Fidler, S. Gupta, I. Soerjomataram, J. Ferlay, E. Steliarova-Foucher, F. Bray, Cancer incidence and mortality among young adults aged 20\u201339 years worldwide in 2012: a population-based study. Lancet Oncol. 18(12), 1579\u20131589 (2017)","journal-title":"Lancet Oncol."},{"issue":"3","key":"4161_CR62","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209\u2013249 (2021)","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"4161_CR63","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ccell.2023.02.012","volume":"41","author":"D Hanahan","year":"2023","unstructured":"D. Hanahan, M. Monje, Cancer hallmarks intersect with neuroscience in the tumor microenvironment. Cancer Cell 41(3), 573\u2013580 (2023)","journal-title":"Cancer Cell"},{"issue":"6","key":"4161_CR64","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1177\/0193945910361332","volume":"32","author":"RH Lehto","year":"2010","unstructured":"R.H. Lehto, L. Song, K.F. Stein, P. Coleman-Burns, Factors influencing prostate cancer screening in African American men. West. J. Nurs. Res. 32(6), 779\u2013793 (2010)","journal-title":"West. J. Nurs. Res."},{"issue":"5","key":"4161_CR65","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1007\/s00520-021-06716-6","volume":"30","author":"OO Bamidele","year":"2022","unstructured":"O.O. Bamidele, O. Alexis, M. Ogunsanya, S. Greenley, A. Worsley, E.D. Mitchell, Barriers and facilitators to accessing and utilising post-treatment psychosocial support by Black men treated for prostate cancer-a systematic review and qualitative synthesis. Support. Care Cancer 30(5), 3665\u20133690 (2022)","journal-title":"Support. Care Cancer"},{"key":"4161_CR66","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1471-2296-15-121","volume":"15","author":"EM Flahavan","year":"2014","unstructured":"E.M. Flahavan, F.J. Drummond, K. Bennett, T.I. Barron, L. Sharp, Prostate specific antigen testing is associated with men\u2019s psychological and physical health and their healthcare utilisation in a nationally representative sample: a cross-sectional study. BMC Fam. Pract. 15, 121 (2014)","journal-title":"BMC Fam. Pract."},{"issue":"3","key":"4161_CR67","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1037\/0022-006X.65.3.414","volume":"65","author":"C Lerman","year":"1997","unstructured":"C. Lerman, M.D. Schwartz, T.H. Lin, C. Hughes, S. Narod, H.T. Lynch, The influence of psychological distress on use of genetic testing for cancer risk. J. Consult. Clin. Psychol. 65(3), 414\u2013420 (1997)","journal-title":"J. Consult. Clin. Psychol."},{"issue":"4","key":"4161_CR68","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/sj.bjc.6602959","volume":"94","author":"J Sweetman","year":"2006","unstructured":"J. Sweetman, M. Watson, A. Norman, Z. Bunstead, P. Hopwood, J. Melia et al. Feasibility of familial PSA screening: psychosocial issues and screening adherence. Br. J. Cancer 94(4), 507\u2013512 (2006)","journal-title":"Br. J. Cancer"},{"key":"4161_CR69","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/539706","volume":"2010","author":"J Tilan","year":"2010","unstructured":"J. Tilan, J. Kitlinska, Sympathetic neurotransmitters and tumor angiogenesis-link between stress and cancer progression. J. Oncol. 2010, 539706 (2010)","journal-title":"J. Oncol."},{"issue":"4","key":"4161_CR70","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1158\/1940-6207.CAPR-10-0358","volume":"4","author":"AK Sood","year":"2011","unstructured":"A.K. Sood, S.K. Lutgendorf, Stress influences on anoikis. Cancer Prev. Res. 4(4), 481\u2013485 (2011)","journal-title":"Cancer Prev. Res."},{"issue":"1","key":"4161_CR71","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1710-1492-4-1-2","volume":"4","author":"FS Dhabhar","year":"2008","unstructured":"F.S. Dhabhar, Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection versus immunopathology. Allergy Asthma Clin. Immunol. 4(1), 2\u201311 (2008)","journal-title":"Allergy Asthma Clin. Immunol."},{"issue":"4","key":"4161_CR72","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41577-023-00949-8","volume":"24","author":"Y Ma","year":"2024","unstructured":"Y. Ma, G. Kroeme, The cancer-immune dialogue in the context of stress. Nat. Rev. Immunol. 24(4), 264\u2013281 (2024). https:\/\/doi.org\/10.1038\/s41577-023-00949-8","journal-title":"Nat. Rev. Immunol."},{"key":"4161_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.709057","volume":"11","author":"Y Lu","year":"2021","unstructured":"Y. Lu, H. Zhao, Y. Liu, Y. Zuo, Q. Xu, L. Liu et al. Chronic stress activates PlexinA1\/VEGFR2-JAK2-STAT3 in vascular endothelial cells to promote angiogenesis. Front. Oncol. 11, 709057 (2021)","journal-title":"Front. Oncol."},{"issue":"1","key":"4161_CR74","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4103\/2230-8210.77573","volume":"15","author":"S Ranabir","year":"2011","unstructured":"S. Ranabir, K. Reetu, Stress and hormones. Indian. J. Endocrinol. Metab. 15(1), 18\u201322 (2011)","journal-title":"Indian. J. Endocrinol. Metab."},{"issue":"6","key":"4161_CR75","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.coph.2009.08.007","volume":"9","author":"I Kyrou","year":"2009","unstructured":"I. Kyrou, C. Tsigos, Stress hormones: physiological stress and regulation of metabolism. Curr. Opin. Pharmacol. 9(6), 787\u2013793 (2009)","journal-title":"Curr. Opin. Pharmacol."},{"issue":"6","key":"4161_CR76","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1055\/s-2007-981462","volume":"39","author":"I Kyrou","year":"2007","unstructured":"I. Kyrou, C. Tsigos, Stress mechanisms and metabolic complications. Horm. Metab. Res. 39(6), 430\u2013438 (2007)","journal-title":"Horm. Metab. Res."},{"issue":"2","key":"4161_CR77","first-page":"216","volume":"25","author":"EV Sukhareva","year":"2021","unstructured":"E.V. Sukhareva, The role of the corticotropin-releasing hormone and its receptors in the regulation of stress response. Vavilovskii Zhurnal Genet. Selektsii 25(2), 216\u2013223 (2021)","journal-title":"Vavilovskii Zhurnal Genet. Selektsii"},{"issue":"2","key":"4161_CR78","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1365-2133.2008.08958.x","volume":"160","author":"A Slominski","year":"2009","unstructured":"A. Slominski, On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders. Br. J. Dermatol. 160(2), 229\u2013232 (2009)","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"4161_CR79","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1210\/jc.2014-2945","volume":"100","author":"AS Karageorgiadis","year":"2015","unstructured":"A.S. Karageorgiadis, G.Z. Papadakis, J. Biro, M.F. Keil, C. Lyssikatos, M.M. Quezado et al. Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone co-secreting tumors in children and adolescents causing cushing syndrome: a diagnostic dilemma and how to solve it. J. Clin. Endocrinol. Metab. 100(1), 141\u2013148 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4161_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-8-30","volume":"8","author":"A Androulidaki","year":"2009","unstructured":"A. Androulidaki, E. Dermitzaki, M. Venihaki, E. Karagianni, O. Rassouli, E. Andreakou et al. Corticotropin releasing factor promotes breast cancer cell motility and invasiveness. Mol. Cancer 8, 30 (2009)","journal-title":"Mol. Cancer"},{"issue":"282","key":"4161_CR81","doi-asserted-by":"publisher","first-page":"ra53","DOI":"10.1126\/scisignal.2003926","volume":"6","author":"S Lal","year":"2013","unstructured":"S. Lal, A. Allan, D. Markovic, R. Walker, J. Macartney, N. Europe-Finner et al. Estrogen alters the splicing of type 1 corticotropin-releasing hormone receptor in breast cancer cells. Sci. Signal. 6(282), ra53 (2013)","journal-title":"Sci. Signal."},{"issue":"1","key":"4161_CR82","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s13277-012-0519-8","volume":"34","author":"E Taliouri","year":"2013","unstructured":"E. Taliouri, T. Vrekoussis, A. Vergetaki, T. Agorastos, A. Makrigiannakis, Corticotropin-releasing hormone (CRH) is expressed in the human cervical carcinoma cells (HeLa) and upregulates the expression of Fas ligand. Tumour Biol. 34(1), 125\u2013130 (2013)","journal-title":"Tumour Biol."},{"issue":"3","key":"4161_CR83","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3390\/ijms22031043","volume":"22","author":"Y Lee","year":"2021","unstructured":"Y. Lee, E.L. Ma, M. Patel, G. Kim, C. Howe, C. Pothoulakis et al. Corticotropin-releasing hormone receptor alters the tumor development and growth in Apcmin\/+ mice and in a chemically-induced model of colon cancer. Int. J. Mol. Sci. 22(3), 1043 (2021)","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"4161_CR84","first-page":"375","volume":"15","author":"G Graziani","year":"2006","unstructured":"G. Graziani, G. Ferrandina, G. Pozzoli, M. Vergati, A. Muzi, F. Legge et al. Corticotropin-releasing hormone receptor-1 in human endometrial cancer. Oncol. Rep. 15(2), 375\u2013379 (2006)","journal-title":"Oncol. Rep."},{"issue":"3","key":"4161_CR85","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3109\/07357907.2013.771269","volume":"31","author":"S Yang","year":"2013","unstructured":"S. Yang, W. Liu, J. Wen, M. Zhu, S. Xu, Corticotropin releasing hormone is correlated with tumorigenesis of gastric cancer. Cancer Invest. 31(3), 167\u2013171 (2013)","journal-title":"Cancer Invest."},{"issue":"11","key":"4161_CR86","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/j.jpedsurg.2008.07.014","volume":"43","author":"J Wang","year":"2008","unstructured":"J. Wang, G. Zhang, Paraneoplastic cushing syndrome because of corticotrophin-releasing hormone-secreting Wilms\u2019 tumor. J. Pediatr. Surg. 43(11), 2099\u20132101 (2008)","journal-title":"J. Pediatr. Surg."},{"issue":"4","key":"4161_CR87","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/07357900701788106","volume":"26","author":"J Wang","year":"2008","unstructured":"J. Wang, Y. Xu, Y. Xu, H. Zhu, R. Zhang, G. Zhang et al. Urocortin\u2019s inhibition of tumor growth and angiogenesis in hepatocellular carcinoma via corticotrophin-releasing factor receptor 2. Cancer Invest. 26(4), 359\u2013368 (2008)","journal-title":"Cancer Invest."},{"issue":"2","key":"4161_CR88","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/sj.jidsp.5640192","volume":"4","author":"Y Funasaka","year":"1999","unstructured":"Y. Funasaka, H. Sato, A.K. Chakraborty, A. Ohashi, G.P. Chrousos, M. Ichihashi, Expression of proopiomelanocortin, corticotropin-releasing hormone (CRH), and CRH receptor in melanoma cells, nevus cells, and normal human melanocytes. J. Investig. Dermatol. Symp. Proc. 4(2), 105\u2013109 (1999)","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"issue":"5","key":"4161_CR89","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/sj.bjc.6603918","volume":"97","author":"V Minas","year":"2007","unstructured":"V. Minas, A. Rolaki, S.N. Kalantaridou, J. Sidiropoulos, S. Mitrou, G. Petsas et al. Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation. Br. J. Cancer 97(5), 637\u2013645 (2007)","journal-title":"Br. J. Cancer"},{"key":"4161_CR90","unstructured":"M.J. Allen, S. Sharma. Physiology, Adrenocorticotropic Hormone (ACTH). In: StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL), 2023). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK500031\/"},{"issue":"23","key":"4161_CR91","doi-asserted-by":"publisher","first-page":"9132","DOI":"10.3390\/ijms21239132","volume":"21","author":"H Fukuoka","year":"2020","unstructured":"H. Fukuoka, H. Shichi, M. Yamamoto, Y. Takahashi, The mechanisms underlying autonomous adrenocorticotropic hormone secretion in Cushing\u2019s disease. Int. J. Mol. Sci. 21(23), 9132 (2020)","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"4161_CR92","first-page":"71","volume":"53","author":"N Uchida","year":"2010","unstructured":"N. Uchida, K. Ishiguro, T. Suda, Y. Horie, M. Nishimura, ACTH-producing breast cancer: a patient report. Yonago Acta Med. 53(4), 71\u201375 (2010)","journal-title":"Yonago Acta Med."},{"issue":"1","key":"4161_CR93","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/biomedicines9010089","volume":"9","author":"S Sparapani","year":"2021","unstructured":"S. Sparapani, C. Millet-Boureima, J. Oliver, K. Mu, P. Hadavi, T. Kalostian et al. The biology of vasopressin. Biomedicines 9(1), 89 (2021)","journal-title":"Biomedicines"},{"key":"4161_CR94","unstructured":"B. Cuzzo, S.A. Padala, S.L. Lappin. Physiology, Vasopressin. In: StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL), 2023). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK526069\/"},{"issue":"11","key":"4161_CR95","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.tins.2012.08.004","volume":"35","author":"ID Neumann","year":"2012","unstructured":"I.D. Neumann, R. Landgraf, Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci. 35(11), 649\u2013659 (2012)","journal-title":"Trends Neurosci."},{"issue":"2","key":"4161_CR96","doi-asserted-by":"publisher","first-page":"330","DOI":"10.9758\/cpn.2022.20.2.330","volume":"20","author":"N Uzun","year":"2022","unstructured":"N. Uzun, O.F. Akca, I. Kilinc, T. Balci, Oxytocin and vasopressin levels and related factors in adolescents with social phobia and other anxiety disorders. Clin. Psychopharmacol. Neurosci. 20(2), 330\u2013342 (2022)","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"Suppl3","key":"4161_CR97","first-page":"S208","volume":"15","author":"BP Pillai","year":"2011","unstructured":"B.P. Pillai, A.G. Unnikrishnan, P.V. Pavithran, Syndrome of inappropriate antidiuretic hormone secretion: revisiting a classical endocrine disorder. Indian. J. Endocrinol. Metab. 15(Suppl3), S208\u2013S215 (2011)","journal-title":"Indian. J. Endocrinol. Metab."},{"key":"4161_CR98","doi-asserted-by":"publisher","unstructured":"W.G. North. Gene regulation of vasopressin and vasopressin receptors in cancer. Exp. Physiol. 85(Spec No), 27S\u201340S (2000). https:\/\/doi.org\/10.1111\/j.1469-445x.2000.tb00005.x","DOI":"10.1111\/j.1469-445x.2000.tb00005.x"},{"issue":"24","key":"4161_CR99","first-page":"7882","volume":"50","author":"AH Taylor","year":"1990","unstructured":"A.H. Taylor, V.T. Ang, J.S. Jenkins, J.J. Silverlight, R.C. Coombes, Y.A. Luqmani, Interaction of vasopressin and oxytocin with human breast carcinoma cells. Cancer Res. 50(24), 7882\u20137886 (1990)","journal-title":"Cancer Res."},{"issue":"7","key":"4161_CR100","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0196-9781(99)00070-4","volume":"20","author":"WG North","year":"1999","unstructured":"W.G. North, M.J. Fay, J. Du, MCF-7 breast cancer cells express normal forms of all vasopressin receptors plus an abnormal V2R. Peptides 20(7), 837\u2013842 (1999)","journal-title":"Peptides"},{"key":"4161_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-8-185","volume":"8","author":"K Hwang","year":"2014","unstructured":"K. Hwang, D.H. Jeon, H.N. Jang, E.J. Bae, J.S. Lee, H.S. Cho et al. Inappropriate antidiuretic hormone syndrome presenting as ectopic antidiuretic hormone-secreting gastric adenocarcinoma: a case report. J. Med. Case Rep. 8, 185 (2014)","journal-title":"J. Med. Case Rep."},{"issue":"12","key":"4161_CR102","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1038\/sj.bjc.6690623","volume":"80","author":"JM Coulson","year":"1999","unstructured":"J.M. Coulson, J. Stanley, P.J. Woll, Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer. Br. J. Cancer 80(12), 1935\u20131944 (1999)","journal-title":"Br. J. Cancer"},{"issue":"1","key":"4161_CR103","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1172\/JCI106784","volume":"51","author":"JM George","year":"1972","unstructured":"J.M. George, C.C. Capen, A.S. Phillips, Biosynthesis of vasopressin in vitro and ultrastructure of a bronchogenic carcinoma. Patient with the syndrome of inappropriate secretion of antidiuretic hormone. J. Clin. Invest. 51(1), 141\u2013148 (1972)","journal-title":"J. Clin. Invest."},{"issue":"3 Pt 1","key":"4161_CR104","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/00005537-199603000-00014","volume":"106","author":"YP Talmi","year":"1996","unstructured":"Y.P. Talmi, G.T. Wolf, H.T. Hoffman, C.J. Krause, Elevated arginine vasopressin levels in squamous cell cancer of the head and neck. Laryngoscope 106(3 Pt 1), 317\u2013321 (1996)","journal-title":"Laryngoscope"},{"issue":"9","key":"4161_CR105","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1001\/archinte.1986.00360210105016","volume":"146","author":"J Osterman","year":"1986","unstructured":"J. Osterman, A. Calhoun, M. Dunham, U.X. Cullum Jr., R.M. Clark, D.D. Stewart et al. Chronic syndrome of inappropriate antidiuretic hormone secretion and hypertension in a patient with olfactory neuroblastoma. Evidence of ectopic production of arginine vasopressin by the tumor. Arch. Intern. Med. 146(9), 1731\u20131735 (1986)","journal-title":"Arch. Intern. Med."},{"issue":"498","key":"4161_CR106","doi-asserted-by":"publisher","first-page":"eaaw4636","DOI":"10.1126\/scitranslmed.aaw4636","volume":"11","author":"N Zhao","year":"2019","unstructured":"N. Zhao, S.O. Peacock, C.H. Lo, L.M. Heidman, M.A. Rice, C.D. Fahrenholtz et al. Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer. Sci. Transl. Med. 11(498), eaaw4636 (2019)","journal-title":"Sci. Transl. Med."},{"key":"4161_CR107","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fonc.2017.00011","volume":"7","author":"M Pifano","year":"2017","unstructured":"M. Pifano, J. Garona, C.S. Capobianco, N. Gonzalez, D.F. Alonso, G.V. Ripoll, Peptide agonists of vasopressin V2 receptor reduce expression of neuroendocrine markers and tumor growth in human lung and prostate tumor cells. Front. Oncol. 7, 11 (2017)","journal-title":"Front. Oncol."},{"issue":"40","key":"4161_CR108","doi-asserted-by":"publisher","first-page":"e27453","DOI":"10.1097\/MD.0000000000027453","volume":"100","author":"J Li","year":"2021","unstructured":"J. Li, X. Zhang, Q. He, W. Feng, L. Ding, Z. Wang et al. Pancreatic neuroendocrine tumor producing vasopressin: a case report. Medicine 100(40), e27453 (2021)","journal-title":"Medicine"},{"key":"4161_CR109","unstructured":"Gonadotropins. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. (National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda (MD), 2018). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548856\/"},{"key":"4161_CR110","unstructured":"P. Marques, K. Skorupskaite, K.S. Rozario, R.A. Anderson, J.T. George, Physiology of GnRH and gonadotropin secretion. In: Feingold K.R., Anawalt B., Blackman M.R., Boyce A., Chrousos G., Corpas E., et al., editors. Endotext. South Dartmouth (MA) (2000)"},{"issue":"1-2","key":"4161_CR111","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mce.2013.08.014","volume":"385","author":"KM Breen","year":"2014","unstructured":"K.M. Breen, P.L. Mellon, Influence of stress-induced intermediates on gonadotropin gene expression in gonadotrope cells. Mol. Cell Endocrinol. 385(1-2), 71\u201377 (2014)","journal-title":"Mol. Cell Endocrinol."},{"key":"4161_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2021.100953","volume":"64","author":"YL Son","year":"2022","unstructured":"Y.L. Son, T. Ubuka, K. Tsutsui, Regulation of stress response on the hypothalamic-pituitary-gonadal axis via gonadotropin-inhibitory hormone. Front. Neuroendocrinol. 64, 100953 (2022)","journal-title":"Front. Neuroendocrinol."},{"issue":"4","key":"4161_CR113","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1210\/er.2006-0036","volume":"28","author":"JH Choi","year":"2007","unstructured":"J.H. Choi, A.S. Wong, H.F. Huang, P.C. Leung, Gonadotropins and ovarian cancer. Endocr. Rev. 28(4), 440\u2013461 (2007)","journal-title":"Endocr. Rev."},{"issue":"6","key":"4161_CR114","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ctrv.2012.12.003","volume":"39","author":"P Limonta","year":"2013","unstructured":"P. Limonta, M. Manea, Gonadotropin-releasing hormone receptors as molecular therapeutic targets in prostate cancer: current options and emerging strategies. Cancer Treat. Rev. 39(6), 647\u2013663 (2013)","journal-title":"Cancer Treat. Rev."},{"key":"4161_CR115","unstructured":"Shahid MA, Ashraf MA, Sharma S. Physiology, Thyroid Hormone. In: StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL), 2023). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK500006\/"},{"key":"4161_CR116","doi-asserted-by":"publisher","unstructured":"D. Grimm, Cell and molecular biology of thyroid disorders. Int. J. Mol. Sci. 20(12) (2019). https:\/\/doi.org\/10.3390\/ijms20122895","DOI":"10.3390\/ijms20122895"},{"issue":"27","key":"4161_CR117","doi-asserted-by":"publisher","first-page":"7606","DOI":"10.1002\/anie.201601116","volume":"55","author":"S Mondal","year":"2016","unstructured":"S. Mondal, K. Raja, U. Schweizer, G. Mugesh, Chemistry and biology in the biosynthesis and action of thyroid hormones. Angew. Chem. Int. Ed. Engl. 55(27), 7606\u20137630 (2016)","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"4161_CR118","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.937957","volume":"28","author":"H Hong","year":"2022","unstructured":"H. Hong, J. Lee, Thyroid-stimulating hormone as a biomarker for stress after thyroid surgery: a prospective cohort study. Med. Sci. Monit. 28, e937957 (2022)","journal-title":"Med. Sci. Monit."},{"issue":"3","key":"4161_CR119","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.yhbeh.2011.06.003","volume":"60","author":"DL Helmreich","year":"2011","unstructured":"D.L. Helmreich, D. Tylee, Thyroid hormone regulation by stress and behavioral differences in adult male rats. Horm. Behav. 60(3), 284\u2013291 (2011)","journal-title":"Horm. Behav."},{"key":"4161_CR120","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fendo.2019.00059","volume":"10","author":"E Krashin","year":"2019","unstructured":"E. Krashin, A. Piekielko-Witkowska, M. Ellis, O. Ashur-Fabian, Thyroid hormones and cancer: a comprehensive review of preclinical and clinical studies. Front. Endocrinol. 10, 59 (2019)","journal-title":"Front. Endocrinol."},{"issue":"3","key":"4161_CR121","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/jcm11030687","volume":"11","author":"IA Voutsadakis","year":"2022","unstructured":"I.A. Voutsadakis, The TSH\/Thyroid hormones axis and breast cancer. J. Clin. Med. 11(3), 687 (2022)","journal-title":"J. Clin. Med."},{"issue":"12","key":"4161_CR122","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1210\/jc.2016-2104","volume":"101","author":"SR Khan","year":"2016","unstructured":"S.R. Khan, L. Chaker, R. Ruiter, J.G. Aerts, A. Hofman, A. Dehghan et al. Thyroid function and cancer risk: the rotterdam study. J. Clin. Endocrinol. Metab. 101(12), 5030\u20135036 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"4161_CR123","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-018-1017-8","volume":"20","author":"C Ortega-Olvera","year":"2018","unstructured":"C. Ortega-Olvera, A. Ulloa-Aguirre, A. Angeles-Llerenas, F.E. Mainero-Ratchelous, C.E. Gonzalez-Acevedo, M.L. Hernandez-Blanco et al. Thyroid hormones and breast cancer association according to menopausal status and body mass index. Breast Cancer Res. 20(1), 94 (2018)","journal-title":"Breast Cancer Res."},{"issue":"5","key":"4161_CR124","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0022-3476(05)80288-4","volume":"119","author":"AL Ogilvy-Stuart","year":"1991","unstructured":"A.L. Ogilvy-Stuart, S.M. Shalet, H.R. Gattamaneni, Thyroid function after treatment of brain tumors in children. J. Pediatr. 119(5), 733\u2013737 (1991)","journal-title":"J. Pediatr."},{"issue":"1","key":"4161_CR125","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/ijms23010436","volume":"23","author":"MV Deligiorgi","year":"2021","unstructured":"M.V. Deligiorgi, D.T. Trafalis, The intriguing thyroid hormones-lung cancer association as exemplification of the thyroid hormones-cancer association: three decades of evolving research. Int. J. Mol. Sci. 23(1), 436 (2021)","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"4161_CR126","doi-asserted-by":"publisher","first-page":"552","DOI":"10.4103\/ijmpo.ijmpo_43_16","volume":"38","author":"K Singh","year":"2017","unstructured":"K. Singh, P. Kumar, R. Pruthy, G. Goyal, Multiple myeloma presenting as thyroid plasmacytoma. Indian. J. Med. Paediatr. Oncol. 38(4), 552\u2013554 (2017)","journal-title":"Indian. J. Med. Paediatr. Oncol."},{"issue":"7","key":"4161_CR127","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/bjc.2017.267","volume":"117","author":"AN Minlikeeva","year":"2017","unstructured":"A.N. Minlikeeva, J.L. Freudenheim, R.A. Cannioto, K.H. Eng, J.B. Szender, P. Mayor et al. History of thyroid disease and survival of ovarian cancer patients: results from the ovarian cancer association consortium, a brief report. Br. J. Cancer 117(7), 1063\u20131069 (2017)","journal-title":"Br. J. Cancer"},{"issue":"10","key":"4161_CR128","doi-asserted-by":"publisher","first-page":"e47730","DOI":"10.1371\/journal.pone.0047730","volume":"7","author":"AM Mondul","year":"2012","unstructured":"A.M. Mondul, S.J. Weinstein, T. Bosworth, A.T. Remaley, J. Virtamo, D. Albanes, Circulating thyroxine, thyroid-stimulating hormone, and hypothyroid status and the risk of prostate cancer. PLoS One 7(10), e47730 (2012)","journal-title":"PLoS One"},{"issue":"2","key":"4161_CR129","doi-asserted-by":"publisher","first-page":"e210581","DOI":"10.1530\/EC-21-0581","volume":"11","author":"B Anguiano","year":"2022","unstructured":"B. Anguiano, C. Montes de Oca, E. Delgado-Gonzalez, C. Aceves, Prostate gland as a target organ of thyroid hormones: advances and controversies. Endocr. Connect. 11(2), e210581 (2022)","journal-title":"Endocr. Connect."},{"key":"4161_CR130","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.951976","volume":"12","author":"MI Bellini","year":"2022","unstructured":"M.I. Bellini, E. Lori, F. Forte, A. Lauro, D. Tripodi, M.I. Amabile et al. Thyroid and renal cancers: a bidirectional association. Front. Oncol. 12, 951976 (2022)","journal-title":"Front. Oncol."},{"key":"4161_CR131","volume":"2016","author":"L Szymanski","year":"2016","unstructured":"L. Szymanski, D. Matak, E. Bartnik, C. Szczylik, A.M. Czarnecka, Thyroid hormones as renal cell cancer regulators. J. Signal. Transduct. 2016, 1362407 (2016)","journal-title":"J. Signal. Transduct."},{"key":"4161_CR132","unstructured":"J.E. Brinkman, M.A. Tariq, L. Leavitt, S. Sharma. Physiology, Growth Hormone. In: StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL), 2023). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482141\/"},{"issue":"3","key":"4161_CR133","first-page":"591","volume":"2","author":"JL Kostyo","year":"1976","unstructured":"J.L. Kostyo, C.R. Reagan, The biology of growth hormone. Pharmacol. Ther. B 2(3), 591\u2013604 (1976)","journal-title":"Pharmacol. Ther. B"},{"issue":"15","key":"4161_CR134","doi-asserted-by":"publisher","first-page":"6031","DOI":"10.1073\/pnas.0507776103","volume":"103","author":"CP Donahue","year":"2006","unstructured":"C.P. Donahue, K.S. Kosik, T.J. Shors, Growth hormone is produced within the hippocampus where it responds to age, sex, and stress. Proc. Natl Acad. Sci. 103(15), 6031\u20136036 (2006)","journal-title":"Proc. Natl Acad. Sci."},{"issue":"5035","key":"4161_CR135","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/210540a0","volume":"210","author":"FC Greenwood","year":"1966","unstructured":"F.C. Greenwood, J. Landon, Growth hormone secretion in response to stress in man. Nature 210(5035), 540\u2013541 (1966)","journal-title":"Nature"},{"issue":"2","key":"4161_CR136","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3345\/kjp.2015.58.2.41","volume":"58","author":"HW Chae","year":"2015","unstructured":"H.W. Chae, D.H. Kim, H.S. Kim, Growth hormone treatment and risk of malignancy. Korean J. Pediatr. 58(2), 41\u201346 (2015)","journal-title":"Korean J. Pediatr."},{"key":"4161_CR137","doi-asserted-by":"publisher","DOI":"10.1177\/2042018820943377","volume":"11","author":"P Beck-Peccoz","year":"2020","unstructured":"P. Beck-Peccoz, C. Hoybye, R.D. Murray, S. Simsek, M. Zabransky, H. Zouater et al. Malignancy risk in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope((R))): data from the PATRO Adults study. Ther. Adv. Endocrinol. Metab. 11, 2042018820943377 (2020)","journal-title":"Ther. Adv. Endocrinol. Metab."},{"issue":"1","key":"4161_CR138","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrendo.2010.171","volume":"7","author":"PE Clayton","year":"2011","unstructured":"P.E. Clayton, I. Banerjee, P.G. Murray, A.G. Renehan, Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nat. Rev. Endocrinol. 7(1), 11\u201324 (2011)","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"4161_CR139","doi-asserted-by":"publisher","first-page":"92","DOI":"10.6065\/apem.2019.24.2.92","volume":"24","author":"S Cianfarani","year":"2019","unstructured":"S. Cianfarani, Risk of cancer in patients treated with recombinant human growth hormone in childhood. Ann. Pediatr. Endocrinol. Metab. 24(2), 92\u201398 (2019)","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"issue":"2","key":"4161_CR140","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1365-2265.2005.02404.x","volume":"64","author":"PJ Jenkins","year":"2006","unstructured":"P.J. Jenkins, A. Mukherjee, S.M. Shalet, Does growth hormone cause cancer? Clin. Endocrinol. 64(2), 115\u2013121 (2006)","journal-title":"Clin. Endocrinol."},{"issue":"42","key":"4161_CR141","doi-asserted-by":"publisher","first-page":"14992","DOI":"10.1073\/pnas.0406396101","volume":"101","author":"MJ Waters","year":"2004","unstructured":"M.J. Waters, B.L. Conway-Campbell, The oncogenic potential of autocrine human growth hormone in breast cancer. Proc. Natl Acad. Sci. 101(42), 14992\u201314993 (2004)","journal-title":"Proc. Natl Acad. Sci."},{"key":"4161_CR142","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ygcen.2015.06.011","volume":"220","author":"RW Lea","year":"2015","unstructured":"R.W. Lea, T. Dawson, C.G. Martinez-Moreno, N. El-Abry, S. Harvey, Growth hormone and cancer: GH production and action in glioma? Gen. Comp. Endocrinol. 220, 119\u2013123 (2015)","journal-title":"Gen. Comp. Endocrinol."},{"issue":"7","key":"4161_CR143","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1083\/jcb.201802095","volume":"217","author":"VL Tokarz","year":"2018","unstructured":"V.L. Tokarz, P.E. MacDonald, A. Klip, The cell biology of systemic insulin function. J. Cell Biol. 217(7), 2273\u20132289 (2018)","journal-title":"J. Cell Biol."},{"issue":"2","key":"4161_CR144","first-page":"19","volume":"26","author":"G Wilcox","year":"2005","unstructured":"G. Wilcox, Insulin and insulin resistance. Clin. Biochem. Rev. 26(2), 19\u201339 (2005)","journal-title":"Clin. Biochem. Rev."},{"key":"4161_CR145","first-page":"317","volume":"21","author":"H Yaribeygi","year":"2022","unstructured":"H. Yaribeygi, M. Maleki, A.E. Butler, T. Jamialahmadi, A. Sahebkar, Molecular mechanisms linking stress and insulin resistance. EXCLI J. 21, 317\u2013334 (2022)","journal-title":"EXCLI J."},{"issue":"5","key":"4161_CR146","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1042\/BCJ20210134","volume":"479","author":"BP Leitner","year":"2022","unstructured":"B.P. Leitner, S. Siebel, N.D. Akingbesote, X. Zhang, R.J. Perry, Insulin and cancer: a tangled web. Biochem. J. 479(5), 583\u2013607 (2022)","journal-title":"Biochem. J."},{"key":"4161_CR147","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/789174","volume":"2012","author":"B Arcidiacono","year":"2012","unstructured":"B. Arcidiacono, S. Iiritano, A. Nocera, K. Possidente, M.T. Nevolo, V. Ventura et al. Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp. Diabetes Res. 2012, 789174 (2012)","journal-title":"Exp. Diabetes Res."},{"issue":"8","key":"4161_CR148","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.tem.2020.05.004","volume":"31","author":"R Vigneri","year":"2020","unstructured":"R. Vigneri, L. Sciacca, P. Vigneri, Rethinking the relationship between insulin and cancer. Trends Endocrinol. Metab. 31(8), 551\u2013560 (2020)","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"4161_CR149","first-page":"3","volume":"39","author":"M Saleem","year":"2018","unstructured":"M. Saleem, H. Martin, P. Coates, Prolactin biology and laboratory measurement: an update on physiology and current analytical issues. Clin. Biochem. Rev. 39(1), 3\u201316 (2018)","journal-title":"Clin. Biochem. Rev."},{"issue":"4","key":"4161_CR150","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","volume":"80","author":"ME Freeman","year":"2000","unstructured":"M.E. Freeman, B. Kanyicska, A. Lerant, G. Nagy, Prolactin: structure, function, and regulation of secretion. Physiol. Rev. 80(4), 1523\u20131631 (2000)","journal-title":"Physiol. Rev."},{"key":"4161_CR151","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9253083","volume":"2018","author":"S Levine","year":"2018","unstructured":"S. Levine, O. Muneyyirci-Delale, Stress-induced hyperprolactinemia: pathophysiology and clinical approach. Obstet. Gynecol. Int. 2018, 9253083 (2018)","journal-title":"Obstet. Gynecol. Int."},{"key":"4161_CR152","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fendo.2016.00025","volume":"7","author":"L Torner","year":"2016","unstructured":"L. Torner, Actions of prolactin in the brain: from physiological adaptations to stress and neurogenesis to psychopathology. Front. Endocrinol. 7, 25 (2016)","journal-title":"Front. Endocrinol."},{"issue":"4","key":"4161_CR153","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.3390\/ijerph20043257","volume":"20","author":"A Faron-Gorecka","year":"2023","unstructured":"A. Faron-Gorecka, K. Latocha, P. Pabian, M. Kolasa, I. Sobczyk-Krupiarz, M. Dziedzicka-Wasylewska, The involvement of prolactin in stress-related disorders. Int. J. Env. Res. Public. Health 20(4), 3257 (2023)","journal-title":"Int. J. Env. Res. Public. Health"},{"issue":"Suppl 2","key":"4161_CR154","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.4103\/2230-8210.104038","volume":"16","author":"BK Sethi","year":"2012","unstructured":"B.K. Sethi, G.V. Chanukya, V.S. Nagesh, Prolactin and cancer: has the orphan finally found a home? Indian. J. Endocrinol. Metab. 16(Suppl 2), S195\u2013S198 (2012)","journal-title":"Indian. J. Endocrinol. Metab."},{"issue":"1","key":"4161_CR155","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-023-01618-3","volume":"25","author":"CA Hathaway","year":"2023","unstructured":"C.A. Hathaway, M.S. Rice, L.C. Collins, D. Chen, D.A. Frank, S. Walker et al. Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers. Breast Cancer Res. 25(1), 24 (2023)","journal-title":"Breast Cancer Res."},{"key":"4161_CR156","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8024171","volume":"2020","author":"MA Fleming 2nd","year":"2020","unstructured":"M.A. Fleming 2nd, L. Ehsan, S.R. Moore, D.E. Levin, The enteric nervous system and its emerging role as a therapeutic target. Gastroenterol. Res. Pract. 2020, 8024171 (2020)","journal-title":"Gastroenterol. Res. Pract."},{"key":"4161_CR157","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-physiol-021317-121515","volume":"81","author":"S Schneider","year":"2019","unstructured":"S. Schneider, C.M. Wright, R.O. Heuckeroth, Unexpected roles for the second brain: enteric nervous system as master regulator of bowel function. Annu. Rev. Physiol. 81, 235\u2013259 (2019)","journal-title":"Annu. Rev. Physiol."},{"issue":"9","key":"4161_CR158","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/nmo.12937","volume":"28","author":"M Million","year":"2016","unstructured":"M. Million, M. Larauche, Stress, sex, and the enteric nervous system. Neurogastroenterol. Motil. 28(9), 1283\u20131289 (2016)","journal-title":"Neurogastroenterol. Motil."},{"issue":"13","key":"4161_CR159","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1016\/j.cell.2023.05.001","volume":"186","author":"KM Schneider","year":"2023","unstructured":"K.M. Schneider, N. Blank, Y. Alvarez, K. Thum, P. Lundgren, L. Litichevskiy et al. The enteric nervous system relays psychological stress to intestinal inflammation. Cell 186(13), 2823\u201338.e20 (2023)","journal-title":"Cell"},{"issue":"1","key":"4161_CR160","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/cancers13010152","volume":"13","author":"SL Schonkeren","year":"2021","unstructured":"S.L. Schonkeren, M.S. Thijssen, N. Vaes, W. Boesmans, V. Melotte, The emerging role of nerves and glia in colorectal cancer. Cancers 13(1), 152 (2021)","journal-title":"Cancers"},{"key":"4161_CR161","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-1-4939-0897-4_3","volume":"817","author":"JB Furness","year":"2014","unstructured":"J.B. Furness, B.P. Callaghan, L.R. Rivera, H.J. Cho, The enteric nervous system and gastrointestinal innervation: integrated local and central control. Adv. Exp. Med. Biol. 817, 39\u201371 (2014)","journal-title":"Adv. Exp. Med. Biol."},{"issue":"7","key":"4161_CR162","first-page":"416","volume":"19","author":"K Ray","year":"2022","unstructured":"K. Ray, Crosstalk between enteric neurons and colorectal cancer stem cells influences self-renewal. Nat. Rev. Gastroenterol. Hepatol. 19(7), 416 (2022)","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"4161_CR163","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","volume":"42","author":"S Ramamoorthy","year":"2016","unstructured":"S. Ramamoorthy, J.A. Cidlowski, Corticosteroids: mechanisms of action in health and disease. Rheum. Dis. Clin. North. Am. 42(1), 15\u201331 (2016)","journal-title":"Rheum. Dis. Clin. North. Am."},{"key":"4161_CR164","unstructured":"M. Yasir, A. Goyal, S. Sonthalia, Corticosteroid Adverse Effects. In: StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL), 2023)."},{"key":"4161_CR165","unstructured":"L. Thau, J. Gandhi, S. Sharm, Physiology, Cortisol. In: StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL), 2023). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538239\/"},{"issue":"2","key":"4161_CR166","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.yfrne.2007.10.002","volume":"29","author":"ER de Kloet","year":"2008","unstructured":"E.R. de Kloet, H. Karst, M. Joels, Corticosteroid hormones in the central stress response: quick-and-slow. Front. Neuroendocrinol. 29(2), 268\u2013272 (2008)","journal-title":"Front. Neuroendocrinol."},{"key":"4161_CR167","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3389\/fimmu.2019.01545","volume":"10","author":"S Timmermans","year":"2019","unstructured":"S. Timmermans, J. Souffriau, C. Libert, A general introduction to glucocorticoid biology. Front. Immunol. 10, 1545 (2019)","journal-title":"Front. Immunol."},{"issue":"5","key":"4161_CR168","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3390\/cells11050770","volume":"11","author":"L Kalfeist","year":"2022","unstructured":"L. Kalfeist, L. Galland, F. Ledys, F. Ghiringhelli, E. Limagne, S. Ladoire, Impact of glucocorticoid use in oncology in the immunotherapy era. Cells 11(5), 770 (2022)","journal-title":"Cells"},{"issue":"3","key":"4161_CR169","first-page":"647","volume":"2","author":"B Scheijen","year":"2019","unstructured":"B. Scheijen, Molecular mechanisms contributing to glucocorticoid resistance in lymphoid malignancies. Cancer Drug. Resist. 2(3), 647\u2013664 (2019)","journal-title":"Cancer Drug. Resist."},{"issue":"2","key":"4161_CR170","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jsbmb.2004.12.017","volume":"93","author":"C Ploner","year":"2005","unstructured":"C. Ploner, S. Schmidt, E. Presul, K. Renner, K. Schr\u00f6cksnadel, J. Rainer et al. Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia. J. Steroid Biochem. Mol. Biol. 93(2), 153\u2013160 (2005)","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"4161_CR171","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1161768","volume":"14","author":"S Khadka","year":"2023","unstructured":"S. Khadka, S.R. Druffner, B.C. Duncan, J.T. Busada, Glucocorticoid regulation of cancer development and progression. Front. Endocrinol. 14, 1161768 (2023)","journal-title":"Front. Endocrinol."},{"issue":"7749","key":"4161_CR172","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-019-1019-4","volume":"567","author":"MMS Obradovic","year":"2019","unstructured":"M.M.S. Obradovic, B. Hamelin, N. Manevski, J.P. Couto, A. Sethi, M.M. Coissieux et al. Glucocorticoids promote breast cancer metastasis. Nature 567(7749), 540\u2013544 (2019)","journal-title":"Nature"},{"issue":"1","key":"4161_CR173","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99224-w","volume":"11","author":"VB Valente","year":"2021","unstructured":"V.B. Valente, D. de Melo Cardoso, G.M. Kayahara, G.B. Nunes, K.C. Tjioe, E.R. Biasoli et al. Stress hormones promote DNA damage in human oral keratinocytes. Sci. Rep. 11(1), 19701 (2021)","journal-title":"Sci. Rep."},{"key":"4161_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpnec.2022.100110","volume":"9","author":"JA Figueira","year":"2022","unstructured":"J.A. Figueira, B.A.M. Sarafim-Silva, G.M. Goncalves, L.N. Aranha, F.L. Lopes, J.E. Corrente et al. Predisposing factors for increased cortisol levels in oral cancer patients. Compr. Psychoneuroendocrinol 9, 100110 (2022)","journal-title":"Compr. Psychoneuroendocrinol"},{"issue":"6","key":"4161_CR175","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/01.HYP.0000193502.77417.17","volume":"46","author":"PJ Fuller","year":"2005","unstructured":"P.J. Fuller, M.J. Young, Mechanisms of mineralocorticoid action. Hypertension 46(6), 1227\u20131235 (2005)","journal-title":"Hypertension"},{"key":"4161_CR176","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1146\/annurev.nu.16.070196.002303","volume":"16","author":"CE Fardella","year":"1996","unstructured":"C.E. Fardella, W.L. Miller, Molecular biology of mineralocorticoid metabolism. Annu. Rev. Nutr. 16, 443\u2013470 (1996)","journal-title":"Annu. Rev. Nutr."},{"issue":"4","key":"4161_CR177","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/hep.27940","volume":"62","author":"H Nie","year":"2015","unstructured":"H. Nie, J. Li, X.M. Yang, Q.Z. Cao, M.X. Feng, F. Xue et al. Mineralocorticoid receptor suppresses cancer progression and the Warburg effect by modulating the miR-338-3p-PKLR axis in hepatocellular carcinoma. Hepatology 62(4), 1145\u20131159 (2015)","journal-title":"Hepatology"},{"issue":"2","key":"4161_CR178","first-page":"408","volume":"13","author":"Y Nagata","year":"2023","unstructured":"Y. Nagata, T. Matsukawa, T. Goto, Y. Teramoto, G. Jiang, N. Fujimoto et al. Protective role of mineralocorticoid receptor signaling in urothelial tumorigenesis. Am. J. Cancer Res. 13(2), 408\u2013418 (2023)","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"4161_CR179","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01355-x","volume":"22","author":"TB Doan","year":"2020","unstructured":"T.B. Doan, V. Cheung, C.D. Clyne, H.N. Hilton, N. Eriksson, M.J. Young et al. A tumour suppressive relationship between mineralocorticoid and retinoic acid receptors activates a transcriptional program consistent with a reverse Warburg effect in breast cancer. Breast Cancer Res. 22(1), 122 (2020)","journal-title":"Breast Cancer Res."},{"key":"4161_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.110278","volume":"369","author":"RK Tiwari","year":"2023","unstructured":"R.K. Tiwari, S.G. Rawat, V.K. Gupta, P.K. Jaiswara, P. Sonker, S. Kumar et al. Epinephrine facilitates the growth of T cell lymphoma by altering cell proliferation, apoptosis, and glucose metabolism. Chem. Biol. Interact. 369, 110278 (2023)","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"4161_CR181","first-page":"1625","volume":"54","author":"X Zhi","year":"2019","unstructured":"X. Zhi, B. Li, Z. Li, J. Zhang, J. Yu, L. Zhang et al. Adrenergic modulation of AMPK\u2011dependent autophagy by chronic stress enhances cell proliferation and survival in gastric cancer. Int. J. Oncol. 54(5), 1625\u20131638 (2019)","journal-title":"Int. J. Oncol."},{"issue":"4","key":"4161_CR182","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3390\/encyclopedia2040111","volume":"2","author":"P Hussar","year":"2022","unstructured":"P. Hussar, Apoptosis regulators Bcl-2 and caspase-3. Encyclopedia 2(4), 1624\u20131636 (2022)","journal-title":"Encyclopedia"},{"issue":"3","key":"4161_CR183","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","volume":"20","author":"R Singh","year":"2019","unstructured":"R. Singh, A. Letai, K. Sarosiek, Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat. Rev. Mol. Cell Biol. 20(3), 175\u2013193 (2019)","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"4161_CR184","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","volume":"170","author":"ER Kastenhuber","year":"2017","unstructured":"E.R. Kastenhuber, S.W. Lowe, Putting p53 in context. Cell 170(6), 1062\u20131078 (2017)","journal-title":"Cell"},{"issue":"1","key":"4161_CR185","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/sj.cdd.4401456","volume":"11","author":"S Schmidt","year":"2004","unstructured":"S. Schmidt, J. Rainer, C. Ploner, E. Presul, S. Riml, R. Kofler, Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ. 11(1), S45\u2013S55 (2004)","journal-title":"Cell Death Differ."},{"issue":"4","key":"4161_CR186","doi-asserted-by":"publisher","first-page":"R343","DOI":"10.1152\/ajpregu.00112.2013","volume":"305","author":"X Feng","year":"2013","unstructured":"X. Feng, S.A. Reini, E. Richards, C.E. Wood, M. Keller-Wood, Cortisol stimulates proliferation and apoptosis in the late gestation fetal heart: differential effects of mineralocorticoid and glucocorticoid receptors. Am. J. Physiol. Regul. Integr. Comp. Physiol 305(4), R343\u2013R350 (2013)","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol"},{"issue":"5-6","key":"4161_CR187","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0145-305X(98)00033-0","volume":"22","author":"FA Weyts","year":"1998","unstructured":"F.A. Weyts, G. Flik, J.H. Rombout, B.M. Verburg-van Kemenade, Cortisol induces apoptosis in activated B cells, not in other lymphoid cells of the common carp, Cyprinus carpio L. Dev. Comp. Immunol. 22(5-6), 551\u2013562 (1998)","journal-title":"Dev. Comp. Immunol."},{"issue":"4","key":"4161_CR188","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","volume":"147","author":"N Mizushima","year":"2011","unstructured":"N. Mizushima, M. Komatsu, Autophagy: renovation of cells and tissues. Cell 147(4), 728\u2013741 (2011)","journal-title":"Cell"},{"issue":"3","key":"4161_CR189","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1089\/ars.2013.5371","volume":"20","author":"KR Parzych","year":"2014","unstructured":"K.R. Parzych, D.J. Klionsky, An overview of autophagy: morphology, mechanism, and regulation. Antioxid. Redox Signal. 20(3), 460\u2013473 (2014)","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"4161_CR190","doi-asserted-by":"publisher","first-page":"149","DOI":"10.21037\/atm-20-8176","volume":"9","author":"Z Zhu","year":"2021","unstructured":"Z. Zhu, R. Yu, C. Yang, D. Li, J. Wang, W. Yang et al. Stress-related hormone reduces autophagy through the regulation of phosphatidylethanolamine in breast cancer cells. Ann. Transl. Med. 9(2), 149 (2021)","journal-title":"Ann. Transl. Med."},{"issue":"9","key":"4161_CR191","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00018-022-04455-3","volume":"79","author":"C Wang","year":"2022","unstructured":"C. Wang, Y. Shen, J. Ni, W. Hu, Y. Yang, Effect of chronic stress on tumorigenesis and development. Cell. Mol. Life Sci. 79(9), 485 (2022)","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"4161_CR192","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1095\/biolreprod.107.065656","volume":"78","author":"J Komiyama","year":"2008","unstructured":"J. Komiyama, R. Nishimura, H.-Y. Lee, R. Sakumoto, M. Tetsuka, T.J. Acosta et al. Cortisol is a suppressor of apoptosis in bovine corpus luteum. Biol. Reprod. 78(5), 888\u2013895 (2008)","journal-title":"Biol. Reprod."},{"key":"4161_CR193","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-018-1360-0","volume":"14","author":"J Dong","year":"2018","unstructured":"J. Dong, J. Li, L. Cui, Y. Wang, J. Lin, Y. Qu et al. Cortisol modulates inflammatory responses in LPS-stimulated RAW264. 7 cells via the NF-\u03baB and MAPK pathways. BMC Vet Res. 14, 1\u201310 (2018)","journal-title":"BMC Vet Res."},{"issue":"3","key":"4161_CR194","first-page":"773","volume":"2","author":"RL Flaherty","year":"2019","unstructured":"R.L. Flaherty, M. Falcinelli, M.S. Flint, Stress and drug resistance in cancer. Cancer Drug. Resist. 2(3), 773\u2013786 (2019)","journal-title":"Cancer Drug. Resist."},{"issue":"12","key":"4161_CR195","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.2217\/fon.10.142","volume":"6","author":"M Moreno-Smith","year":"2010","unstructured":"M. Moreno-Smith, S.K. Lutgendorf, A.K. Sood, Impact of stress on cancer metastasis. Future Oncol. 6(12), 1863\u20131881 (2010)","journal-title":"Future Oncol."},{"issue":"13","key":"4161_CR196","doi-asserted-by":"publisher","first-page":"10944","DOI":"10.3390\/ijms241310944","volume":"24","author":"J Zhang","year":"2023","unstructured":"J. Zhang, Q. Xiang, M. Wu, Y.Z. Lao, Y.F. Xian, H.X. Xu et al. Autophagy regulators in cancer. Int. J. Mol. Sci. 24(13), 10944 (2023)","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"4161_CR197","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","volume":"8","author":"V Panwar","year":"2023","unstructured":"V. Panwar, A. Singh, M. Bhatt, R.K. Tonk, S. Azizov, A.S. Raza et al. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. Signal. Transduct. Target. Ther. 8(1), 375 (2023)","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"2","key":"4161_CR198","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"J. Kim, M. Kundu, B. Viollet, K.L. Guan, AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13(2), 132\u2013141 (2011)","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"4161_CR199","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.trecan.2021.10.005","volume":"8","author":"H Wackerhage","year":"2022","unstructured":"H. Wackerhage, J.F. Christensen, M. Ilmer, I. von Luettichau, B.W. Renz, M. Schonfelder, Cancer catecholamine conundrum. Trends Cancer 8(2), 110\u2013122 (2022)","journal-title":"Trends Cancer"},{"issue":"1","key":"4161_CR200","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4161\/cbt.10.1.12260","volume":"10","author":"EV Yang","year":"2010","unstructured":"E.V. Yang, Role for catecholamines in tumor progression: possible use for beta-blockers in the treatment of cancer. Cancer Biol. Ther. 10(1), 30\u201332 (2010)","journal-title":"Cancer Biol. Ther."},{"key":"4161_CR201","unstructured":"S. Paravati, A. Rosani, S.J. Warrington, Physiology, Catecholamines. In: StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL), 2024). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507716\/"},{"issue":"1","key":"4161_CR202","first-page":"45","volume":"48","author":"VI Kulinskii","year":"2002","unstructured":"V.I. Kulinskii, L.S. Kolesnichenko, [Catecholamines: biochemistry, pharmacology, physiology, clinical aspects]. Vopr. Med. Khim 48(1), 45\u201367 (2002)","journal-title":"Vopr. Med. Khim"},{"key":"4161_CR203","unstructured":"L.S. Hussain, V. Reddy, C.V. Maani, Physiology, Noradrenergic Synapse. In: StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL), 2023). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK540977\/"},{"issue":"1","key":"4161_CR204","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1006\/exnr.1996.6379","volume":"144","author":"JD Elsworth","year":"1997","unstructured":"J.D. Elsworth, R.H. Roth, Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson\u2019s disease. Exp. Neurol. 144(1), 4\u20139 (1997)","journal-title":"Exp. Neurol."},{"key":"4161_CR205","unstructured":"S. Kamal, S.L. Lappin, Biochemistry, Catecholamine Degradation. In: StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL): 2023)"},{"issue":"22","key":"4161_CR206","first-page":"1113","volume":"26","author":"E Schwarz-Tiene","year":"1974","unstructured":"E. Schwarz-Tiene, G. Chiumello, [Importance of catecholamines in the physiology and pathology of childhood]. Minerva Pediatr. 26(22), 1113\u20131117 (1974)","journal-title":"Minerva Pediatr."},{"issue":"4","key":"4161_CR207","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5688\/aj710478","volume":"71","author":"LK McCorry","year":"2007","unstructured":"L.K. McCorry, Physiology of the autonomic nervous system. Am. J. Pharm. Educ. 71(4), 78 (2007)","journal-title":"Am. J. Pharm. Educ."},{"key":"4161_CR208","doi-asserted-by":"publisher","unstructured":"Stanford S.C. Norepinephrine and epinephrine: introduction. Encyclopedia Life Sci. 1\u20137. https:\/\/doi.org\/10.1002\/9780470015902.a0000271.pub3","DOI":"10.1002\/9780470015902.a0000271.pub3"},{"key":"4161_CR209","unstructured":"Dalal R., Grujic D. Epinephrine. In: StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL), 2024). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482160\/"},{"key":"4161_CR210","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9730467","volume":"2016","author":"H Juarez Olguin","year":"2016","unstructured":"H. Juarez Olguin, D. Calderon Guzman, E. Hernandez Garcia, G. Barragan Mejia, The role of dopamine and its dysfunction as a consequence of oxidative stress. Oxid. Med. Cell Longev. 2016, 9730467 (2016)","journal-title":"Oxid. Med. Cell Longev."},{"key":"4161_CR211","unstructured":"A. Bhatia, J.R. Lenchner, A. Saadabadi, Biochemistry, Dopamine Receptors. In: StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL), 2023). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538242\/"},{"issue":"3-4","key":"4161_CR212","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ando.2020.03.012","volume":"82","author":"J Motiejunaite","year":"2021","unstructured":"J. Motiejunaite, L. Amar, E. Vidal-Petiot, Adrenergic receptors and cardiovascular effects of catecholamines. Ann. Endocrinol. 82(3-4), 193\u2013197 (2021)","journal-title":"Ann. Endocrinol."},{"issue":"5","key":"4161_CR213","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3949\/ccjm.57.5.481","volume":"57","author":"RM Graham","year":"1990","unstructured":"R.M. Graham, Adrenergic receptors: structure and function. Cleve Clin. J. Med. 57(5), 481\u2013491 (1990)","journal-title":"Cleve Clin. J. Med."},{"issue":"4","key":"4161_CR214","doi-asserted-by":"publisher","first-page":"a005900","DOI":"10.1101\/cshperspect.a005900","volume":"8","author":"CH Heldin","year":"2016","unstructured":"C.H. Heldin, B. Lu, R. Evans, J.S. Gutkind, Signals and receptors. Cold Spring Harb. Perspect. Biol. 8(4), a005900 (2016)","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"11","key":"4161_CR215","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1016\/S0021-9258(19)69281-1","volume":"256","author":"RG Shorr","year":"1981","unstructured":"R.G. Shorr, R.J. Lefkowitz, M.G. Caron, Purification of the beta-adrenergic receptor. Identification of the hormone binding subunit. J. Biol. Chem. 256(11), 5820\u20135826 (1981)","journal-title":"J. Biol. Chem."},{"key":"4161_CR216","doi-asserted-by":"publisher","unstructured":"H. Wackerhage, J.F. Christensen, M. Ilmer, I. von Luettichau, B.W. Renz, Schonfelder M. Cancer catecholamine conundrum. Trends Cancer. (2021). https:\/\/doi.org\/10.1016\/j.trecan.2021.10.005","DOI":"10.1016\/j.trecan.2021.10.005"},{"issue":"2","key":"4161_CR217","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1158\/1541-7786.MCR-11-0332","volume":"10","author":"MH Al-Wadei","year":"2012","unstructured":"M.H. Al-Wadei, H.A. Al-Wadei, H.M. Schuller, Pancreatic cancer cells and normal pancreatic duct epithelial cells express an autocrine catecholamine loop that is activated by nicotinic acetylcholine receptors alpha3, alpha5, and alpha7. Mol. Cancer Res. 10(2), 239\u2013249 (2012)","journal-title":"Mol. Cancer Res."},{"issue":"8","key":"4161_CR218","doi-asserted-by":"publisher","first-page":"e0202515","DOI":"10.1371\/journal.pone.0202515","volume":"13","author":"DB Bastos","year":"2018","unstructured":"D.B. Bastos, B.A.M. Sarafim-Silva, M. Sundefeld, A.A. Ribeiro, J.D.P. Brandao, E.R. Biasoli et al. Circulating catecholamines are associated with biobehavioral factors and anxiety symptoms in head and neck cancer patients. PLoS One 13(8), e0202515 (2018)","journal-title":"PLoS One"},{"issue":"2","key":"4161_CR219","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4149\/endo_2011_02_65","volume":"45","author":"K Pacak","year":"2011","unstructured":"K. Pacak, Phaeochromocytoma: a catecholamine and oxidative stress disorder. Endocr. Regul. 45(2), 65\u201390 (2011)","journal-title":"Endocr. Regul."},{"key":"4161_CR220","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bbi.2019.06.004","volume":"81","author":"Y Xia","year":"2019","unstructured":"Y. Xia, Y. Wei, Z.Y. Li, X.Y. Cai, L.L. Zhang, X.R. Dong et al. Catecholamines contribute to the neovascularization of lung cancer via tumor-associated macrophages. Brain Behav. Immun. 81, 111\u2013121 (2019)","journal-title":"Brain Behav. Immun."},{"issue":"11","key":"4161_CR221","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.oraloncology.2015.08.007","volume":"51","author":"H Xie","year":"2015","unstructured":"H. Xie, C. Li, Y. He, R. Griffin, Q. Ye, L. Li, Chronic stress promotes oral cancer growth and angiogenesis with increased circulating catecholamine and glucocorticoid levels in a mouse model. Oral. Oncol. 51(11), 991\u2013997 (2015)","journal-title":"Oral. Oncol."},{"issue":"8","key":"4161_CR222","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1158\/1078-0432.CCR-07-1778","volume":"14","author":"C Sarkar","year":"2008","unstructured":"C. Sarkar, D. Chakroborty, U.R. Chowdhury, P.S. Dasgupta, S. Basu, Dopamine increases the efficacy of anticancer drugs in breast and colon cancer preclinical models. Clin. Cancer Res. 14(8), 2502\u20132510 (2008)","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"4161_CR223","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/carcin\/bgac045","volume":"43","author":"CE Grant","year":"2022","unstructured":"C.E. Grant, A.L. Flis, B.M. Ryan, Understanding the role of dopamine in cancer: past, present and future. Carcinogenesis 43(6), 517\u2013527 (2022)","journal-title":"Carcinogenesis"},{"issue":"1","key":"4161_CR224","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1124\/jpet.119.256818","volume":"370","author":"JS Weissenrieder","year":"2019","unstructured":"J.S. Weissenrieder, J.D. Neighbors, R.B. Mailman, R.J. Hohl, Cancer and the dopamine D(2) receptor: a pharmacological perspective. J. Pharmacol. Exp. Ther. 370(1), 111\u2013126 (2019)","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"4161_CR225","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1023\/A:1018862309440","volume":"42","author":"S Basu","year":"1997","unstructured":"S. Basu, P.S. Dasgupta, Alteration of dopamine D2 receptors in human malignant stomach tissue. Dig. Dis. Sci. 42(6), 1260\u20131264 (1997)","journal-title":"Dig. Dis. Sci."},{"issue":"6","key":"4161_CR226","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1159\/000492644","volume":"48","author":"XY Wu","year":"2018","unstructured":"X.Y. Wu, C.X. Zhang, L.C. Deng, J. Xiao, X. Yuan, B. Zhang et al. Overexpressed D2 dopamine receptor inhibits non-small cell lung cancer progression through inhibiting NF-kappaB signaling pathway. Cell Physiol. Biochem. 48(6), 2258\u20132272 (2018)","journal-title":"Cell Physiol. Biochem."},{"issue":"4","key":"4161_CR227","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1172\/JCI33125","volume":"118","author":"D Chakroborty","year":"2008","unstructured":"D. Chakroborty, U.R. Chowdhury, C. Sarkar, R. Baral, P.S. Dasgupta, S. Basu, Dopamine regulates endothelial progenitor cell mobilization from mouse bone marrow in tumor vascularization. J. Clin. Invest. 118(4), 1380\u20131389 (2008)","journal-title":"J. Clin. Invest."},{"key":"4161_CR228","doi-asserted-by":"publisher","DOI":"10.1038\/srep45686","volume":"7","author":"K Minami","year":"2017","unstructured":"K. Minami, S. Liu, Y. Liu, A. Chen, Q. Wan, S. Na et al. Inhibitory effects of dopamine receptor D(1) agonist on mammary tumor and bone metastasis. Sci. Rep. 7, 45686 (2017)","journal-title":"Sci. Rep."},{"issue":"11","key":"4161_CR229","doi-asserted-by":"publisher","first-page":"jcs259617","DOI":"10.1242\/jcs.259617","volume":"135","author":"C Sarkar","year":"2022","unstructured":"C. Sarkar, D. Chakroborty, S. Goswami, H. Fan, X. Mo, S. Basu, VEGF-A controls the expression of its regulator of angiogenic functions, dopamine D2 receptor, on endothelial cells. J. Cell Sci. 135(11), jcs259617 (2022)","journal-title":"J. Cell Sci."},{"issue":"6","key":"4161_CR230","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.ccell.2016.05.002","volume":"29","author":"S Dolma","year":"2016","unstructured":"S. Dolma, H.J. Selvadurai, X. Lan, L. Lee, M. Kushida, V. Voisin et al. Inhibition of dopamine receptor D4 impedes autophagic flux, proliferation, and survival of glioblastoma stem cells. Cancer Cell 29(6), 859\u2013873 (2016)","journal-title":"Cancer Cell"},{"issue":"6","key":"4161_CR231","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1053\/j.gastro.2016.08.040","volume":"151","author":"P Jandaghi","year":"2016","unstructured":"P. Jandaghi, H.S. Najafabadi, A.S. Bauer, A.I. Papadakis, M. Fassan, A. Hall et al. Expression of DRD2 is increased in human pancreatic ductal adenocarcinoma and inhibitors slow tumor growth in mice. Gastroenterology 151(6), 1218\u20131231 (2016)","journal-title":"Gastroenterology"},{"key":"4161_CR232","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/CLEP.S33695","volume":"4","author":"PJ Fitzgerald","year":"2012","unstructured":"P.J. Fitzgerald, Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint. Clin. Epidemiol. 4, 151\u2013156 (2012)","journal-title":"Clin. Epidemiol."},{"issue":"2","key":"4161_CR233","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ijc.24063","volume":"124","author":"PJ Fitzgerald","year":"2009","unstructured":"P.J. Fitzgerald, Is norepinephrine an etiological factor in some types of cancer? Int. J. Cancer 124(2), 257\u2013263 (2009)","journal-title":"Int. J. Cancer"},{"key":"4161_CR234","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2020.104712","volume":"113","author":"B Zhang","year":"2020","unstructured":"B. Zhang, C. Wu, W. Chen, L. Qiu, S. Li, T. Wang et al. The stress hormone norepinephrine promotes tumor progression through beta2-adrenoreceptors in oral cancer. Arch. Oral. Biol. 113, 104712 (2020)","journal-title":"Arch. Oral. Biol."},{"issue":"4","key":"4161_CR235","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1530\/ERC-20-0460","volume":"29","author":"KC Tjioe","year":"2022","unstructured":"K.C. Tjioe, D.M. Cardoso, S.H.P. Oliveira, D.G. Bernabe, Stress hormone norepinephrine incites resistance of oral cancer cells to chemotherapy. Endocr. Relat. Cancer 29(4), 201\u2013212 (2022)","journal-title":"Endocr. Relat. Cancer"},{"key":"4161_CR236","volume":"2021","author":"Y Wang","year":"2021","unstructured":"Y. Wang, S. Wang, Q. Yang, J. Li, F. Yu, E. Zhao, Norepinephrine enhances aerobic glycolysis and may act as a predictive factor for immunotherapy in gastric cancer. J. Immunol. Res. 2021, 5580672 (2021)","journal-title":"J. Immunol. Res."},{"issue":"7","key":"4161_CR237","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.18632\/oncotarget.2652","volume":"6","author":"M Calvani","year":"2015","unstructured":"M. Calvani, F. Pelon, G. Comito, M.L. Taddei, S. Moretti, S. Innocenti et al. Norepinephrine promotes tumor microenvironment reactivity through beta3-adrenoreceptors during melanoma progression. Oncotarget 6(7), 4615\u20134632 (2015)","journal-title":"Oncotarget"},{"issue":"2","key":"4161_CR238","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3892\/ijo.2015.3038","volume":"47","author":"A Barbieri","year":"2015","unstructured":"A. Barbieri, S. Bimonte, G. Palma, A. Luciano, D. Rea, A. Giudice et al. The stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo. Int. J. Oncol. 47(2), 527\u2013534 (2015)","journal-title":"Int. J. Oncol."},{"issue":"1","key":"4161_CR239","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09330-9","volume":"22","author":"X Wang","year":"2022","unstructured":"X. Wang, Y. Wang, F. Xie, Z.T. Song, Z.Q. Zhang, Y. Zhao et al. Norepinephrine promotes glioma cell migration through up-regulating the expression of Twist1. BMC Cancer 22(1), 213 (2022)","journal-title":"BMC Cancer"},{"issue":"6","key":"4161_CR240","first-page":"1932","volume":"12","author":"X Ouyang","year":"2019","unstructured":"X. Ouyang, Z. Zhu, C. Yang, L. Wang, G. Ding, F. Jiang, Epinephrine increases malignancy of breast cancer through p38 MAPK signaling pathway in depressive disorders. Int. J. Clin. Exp. Pathol. 12(6), 1932\u20131946 (2019)","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"4161_CR241","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.bbi.2017.02.008","volume":"62","author":"R Muthuswamy","year":"2017","unstructured":"R. Muthuswamy, N.J. Okada, F.J. Jenkins, K. McGuire, P.F. McAuliffe, H.J. Zeh et al. Epinephrine promotes COX-2-dependent immune suppression in myeloid cells and cancer tissues. Brain Behav. Immun. 62, 78\u201386 (2017)","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"4161_CR242","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1172\/JCI121685","volume":"129","author":"B Cui","year":"2019","unstructured":"B. Cui, Y. Luo, P. Tian, F. Peng, J. Lu, Y. Yang et al. Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cells. J. Clin. Invest. 129(3), 1030\u20131046 (2019)","journal-title":"J. Clin. Invest."},{"issue":"2","key":"4161_CR243","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.bbrc.2012.09.126","volume":"428","author":"J Pu","year":"2012","unstructured":"J. Pu, D. Bai, X. Yang, X. Lu, L. Xu, J. Lu, Adrenaline promotes cell proliferation and increases chemoresistance in colon cancer HT29 cells through induction of miR-155. Biochem. Biophys. Res. Commun. 428(2), 210\u2013215 (2012)","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"4161_CR244","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03467-8","volume":"20","author":"Z Zhou","year":"2022","unstructured":"Z. Zhou, Y. Shu, H. Bao, S. Han, Z. Liu, N. Zhao et al. Stress-induced epinephrine promotes epithelial-to-mesenchymal transition and stemness of CRC through the CEBPB\/TRIM2\/P53 axis. J. Transl. Med. 20(1), 262 (2022)","journal-title":"J. Transl. Med."},{"issue":"28","key":"4161_CR245","doi-asserted-by":"publisher","first-page":"7105","DOI":"10.1200\/JCO.2005.10.015","volume":"23","author":"SK Lutgendorf","year":"2005","unstructured":"S.K. Lutgendorf, A.K. Sood, B. Anderson, S. McGinn, H. Maiseri, M. Dao et al. Social support, psychological distress, and natural killer cell activity in ovarian cancer. J. Clin. Oncol. 23(28), 7105\u20137113 (2005)","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"4161_CR246","first-page":"4514","volume":"9","author":"SK Lutgendorf","year":"2003","unstructured":"S.K. Lutgendorf, S. Cole, E. Costanzo, S. Bradley, J. Coffin, S. Jabbari et al. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin. Cancer Res. 9(12), 4514\u20134521 (2003)","journal-title":"Clin. Cancer Res."},{"issue":"572","key":"4161_CR247","doi-asserted-by":"publisher","first-page":"eabb5817","DOI":"10.1126\/scitranslmed.abb5817","volume":"12","author":"M Perego","year":"2020","unstructured":"M. Perego, V.A. Tyurin, Y.Y. Tyurina, J. Yellets, T. Nacarelli, C. Lin et al. Reactivation of dormant tumor cells by modified lipids derived from stress-activated neutrophils. Sci. Transl. Med. 12(572), eabb5817 (2020)","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"4161_CR248","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nm1447","volume":"12","author":"PH Thaker","year":"2006","unstructured":"P.H. Thaker, L.Y. Han, A.A. Kamat, J.M. Arevalo, R. Takahashi, C. Lu et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat. Med. 12(8), 939\u2013944 (2006)","journal-title":"Nat. Med."},{"issue":"19","key":"4161_CR249","doi-asserted-by":"publisher","first-page":"14094","DOI":"10.1074\/jbc.M611370200","volume":"282","author":"KS Sastry","year":"2007","unstructured":"K.S. Sastry, Y. Karpova, S. Prokopovich, A.J. Smith, B. Essau, A. Gersappe et al. Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation. J. Biol. Chem. 282(19), 14094\u201314100 (2007)","journal-title":"J. Biol. Chem."},{"key":"4161_CR250","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bbi.2014.02.019","volume":"40","author":"C Kim-Fuchs","year":"2014","unstructured":"C. Kim-Fuchs, C.P. Le, M.A. Pimentel, D. Shackleford, D. Ferrari, E. Angst et al. Chronic stress accelerates pancreatic cancer growth and invasion: a critical role for beta-adrenergic signaling in the pancreatic microenvironment. Brain Behav. Immun. 40, 40\u201347 (2014)","journal-title":"Brain Behav. Immun."},{"key":"4161_CR251","first-page":"1057","volume":"16","author":"H Yaribeygi","year":"2017","unstructured":"H. Yaribeygi, Y. Panahi, H. Sahraei, T.P. Johnston, A. Sahebkar, The impact of stress on body function: a review. EXCLI J. 16, 1057\u20131072 (2017)","journal-title":"EXCLI J."},{"issue":"5","key":"4161_CR252","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"D. Hanahan, R.A. Weinberg, Hallmarks of cancer: the next generation. Cell 144(5), 646\u2013674 (2011)","journal-title":"Cell"},{"issue":"1","key":"4161_CR253","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"D. Hanahan, Hallmarks of cancer: new dimensions. Cancer Discov. 12(1), 31\u201346 (2022)","journal-title":"Cancer Discov."},{"issue":"5","key":"4161_CR254","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/em.22087","volume":"58","author":"N Chatterjee","year":"2017","unstructured":"N. Chatterjee, G.C. Walker, Mechanisms of DNA damage, repair, and mutagenesis. Env. Mol. Mutagen. 58(5), 235\u2013263 (2017)","journal-title":"Env. Mol. Mutagen."},{"issue":"2","key":"4161_CR255","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2174\/157339412800675351","volume":"8","author":"HM Schuller","year":"2012","unstructured":"H.M. Schuller, H.A. Al-Wadei, Beta-adrenergic signaling in the development and progression of pulmonary and pancreatic adenocarcinoma. Curr. Cancer Ther. Rev. 8(2), 116\u2013127 (2012)","journal-title":"Curr. Cancer Ther. Rev."},{"issue":"6","key":"4161_CR256","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.3390\/ijms21062250","volume":"21","author":"R Lamboy-Caraballo","year":"2020","unstructured":"R. Lamboy-Caraballo, C. Ortiz-Sanchez, A. Acevedo-Santiago, J. Matta, A.N.A. Monteiro, G.N. Armaiz-Pena, Norepinephrine-induced DNA damage in ovarian cancer cells. Int. J. Mol. Sci. 21(6), 2250 (2020)","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"4161_CR257","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3109\/10253890.2012.686075","volume":"16","author":"MS Flint","year":"2013","unstructured":"M.S. Flint, A. Baum, B. Episcopo, K.Z. Knickelbein, A.J. Liegey Dougall, W.H. Chambers et al. Chronic exposure to stress hormones promotes transformation and tumorigenicity of 3T3 mouse fibroblasts. Stress 16(1), 114\u2013121 (2013)","journal-title":"Stress"},{"issue":"5","key":"4161_CR258","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.psyneuen.2007.02.013","volume":"32","author":"MS Flint","year":"2007","unstructured":"M.S. Flint, A. Baum, W.H. Chambers, F.J. Jenkins, Induction of DNA damage, alteration of DNA repair and transcriptional activation by stress hormones. Psychoneuroendocrinology 32(5), 470\u2013479 (2007)","journal-title":"Psychoneuroendocrinology"},{"issue":"7364","key":"4161_CR259","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature10368","volume":"477","author":"MR Hara","year":"2011","unstructured":"M.R. Hara, J.J. Kovacs, E.J. Whalen, S. Rajagopal, R.T. Strachan, W. Grant et al. A stress response pathway regulates DNA damage through beta2-adrenoreceptors and beta-arrestin-1. Nature 477(7364), 349\u2013353 (2011)","journal-title":"Nature"},{"key":"4161_CR260","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.bbi.2020.11.005","volume":"93","author":"B Cui","year":"2021","unstructured":"B. Cui, F. Peng, J. Lu, B. He, Q. Su, H. Luo et al. Cancer and stress: NextGen strategies. Brain Behav. Immun. 93, 368\u2013383 (2021)","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"4161_CR261","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11481-019-09891-w","volume":"15","author":"MB Nilsson","year":"2020","unstructured":"M.B. Nilsson, X. Le, J.V. Heymach, beta-adrenergic signaling in lung cancer: a potential role for beta-blockers. J. Neuroimmune Pharmacol. 15(1), 27\u201336 (2020)","journal-title":"J. Neuroimmune Pharmacol."},{"key":"4161_CR262","doi-asserted-by":"publisher","unstructured":"Tiwari RK, Rawat SG, Kumar A. The antagonist of \u03b2-adrenergic receptor propranolol inhibits T cell lymphoma growth and enhances antitumor efficacy of cisplatin in vivo: A role of modulated apoptosis, glucose metabolism, pHregulation, and antitumor immune response. Int Immunopharmacol. 124(Pt A):110825 (2023). https:\/\/doi.org\/10.1016\/j.intimp.2023.110825","DOI":"10.1016\/j.intimp.2023.110825"},{"issue":"1","key":"4161_CR263","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/jcb.21802","volume":"105","author":"X Liu","year":"2008","unstructured":"X. Liu, W.K. Wu, L. Yu, J.J. Sung, G. Srivastava, S.T. Zhang et al. Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase\/cyclooxygenase-2 pathway. J. Cell Biochem. 105(1), 53\u201360 (2008)","journal-title":"J. Cell Biochem."},{"issue":"3","key":"4161_CR264","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.bbrc.2017.09.146","volume":"493","author":"J Pu","year":"2017","unstructured":"J. Pu, X. Zhang, H. Luo, L. Xu, X. Lu, J. Lu, Adrenaline promotes epithelial-to-mesenchymal transition via HuR-TGFbeta regulatory axis in pancreatic cancer cells and the implication in cancer prognosis. Biochem. Biophys. Res. Commun. 493(3), 1273\u20131279 (2017)","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"4161_CR265","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41420-022-00818-8","volume":"8","author":"Y Xu","year":"2022","unstructured":"Y. Xu, J. Wang, X. Wang, X. Zhou, J. Tang, X. Jie et al. Targeting ADRB2 enhances sensitivity of non-small cell lung cancer to VEGFR2 tyrosine kinase inhibitors. Cell Death Discov. 8(1), 36 (2022)","journal-title":"Cell Death Discov."},{"issue":"4","key":"4161_CR266","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.3390\/ijms22042042","volume":"22","author":"AM Mehedinteanu","year":"2021","unstructured":"A.M. Mehedinteanu, V. Sfredel, P.O. Stovicek, M. Schenker, G.C. Tartea, O. Istratoaie et al. Assessment of epinephrine and norepinephrine in gastric carcinoma. Int. J. Mol. Sci. 22(4), 2042 (2021)","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"4161_CR267","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"D. Hanahan, R.A. Weinberg, The hallmarks of cancer. Cell 100(1), 57\u201370 (2000)","journal-title":"Cell"},{"key":"4161_CR268","unstructured":"J.K. Bar, E. Sobanska, A. Popiela, M. Goluda, Evaluation of expression and correlation between P53, BCL-2 and BAX proteins in ovarian neoplasms. Ginekol. Pol. 73(2), 102\u2013109 (2002)"},{"issue":"2","key":"4161_CR269","first-page":"874","volume":"123","author":"S Hassan","year":"2013","unstructured":"S. Hassan, Y. Karpova, D. Baiz, D. Yancey, A. Pullikuth, A. Flores et al. Behavioral stress accelerates prostate cancer development in mice. J. Clin. Invest. 123(2), 874\u2013886 (2013)","journal-title":"J. Clin. Invest."},{"issue":"5","key":"4161_CR270","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"R.J. DeBerardinis, N.S. Chandel, Fundamentals of cancer metabolism. Sci. Adv. 2(5), e1600200 (2016)","journal-title":"Sci. Adv."},{"issue":"3191","key":"4161_CR271","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"O. Warburg, On the origin of cancer cells. Science 123(3191), 309\u2013314 (1956)","journal-title":"Science"},{"issue":"3","key":"4161_CR272","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"M.V. Liberti, J.W. Locasale, The warburg effect: how does it benefit cancer cells? Trends Biochem. Sci. 41(3), 211\u2013218 (2016)","journal-title":"Trends Biochem. Sci."},{"issue":"2 Pt 1","key":"4161_CR273","first-page":"E157","volume":"247","author":"RS Sherwin","year":"1984","unstructured":"R.S. Sherwin, L. Sacca, Effect of epinephrine on glucose metabolism in humans: contribution of the liver. Am. J. Physiol. 247(2 Pt 1), E157\u2013E165 (1984)","journal-title":"Am. J. Physiol."},{"issue":"3","key":"4161_CR274","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/vhrm.2006.2.3.213","volume":"2","author":"N Nishida","year":"2006","unstructured":"N. Nishida, H. Yano, T. Nishida, T. Kamura, M. Kojiro, Angiogenesis in cancer. Vasc. Health Risk Manag. 2(3), 213\u2013219 (2006)","journal-title":"Vasc. Health Risk Manag."},{"issue":"9","key":"4161_CR275","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","volume":"77","author":"R Lugano","year":"2020","unstructured":"R. Lugano, M. Ramachandran, A. Dimberg, Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol. Life Sci. 77(9), 1745\u20131770 (2020)","journal-title":"Cell Mol. Life Sci."},{"issue":"11","key":"4161_CR276","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/onc.2016.319","volume":"36","author":"M Hulsurkar","year":"2017","unstructured":"M. Hulsurkar, Z. Li, Y. Zhang, X. Li, D. Zheng, W. Li, Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1. Oncogene 36(11), 1525\u20131536 (2017)","journal-title":"Oncogene"},{"issue":"1","key":"4161_CR277","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1026548715669","volume":"18","author":"W Wu","year":"2000","unstructured":"W. Wu, J. Murata, K. Murakami, T. Yamaura, K. Hayashi, I. Saiki, Social isolation stress augments angiogenesis induced by colon 26-L5 carcinoma cells in mice. Clin. Exp. Metastasis 18(1), 1\u201310 (2000)","journal-title":"Clin. Exp. Metastasis"},{"issue":"2","key":"4161_CR278","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000478517","volume":"138","author":"Y Liu","year":"2017","unstructured":"Y. Liu, X. Yu, J. Zhuang, Epinephrine stimulates cell proliferation and induces chemoresistance in myeloma cells through the beta-adrenoreceptor in vitro. Acta Haematol. 138(2), 103\u2013110 (2017)","journal-title":"Acta Haematol."},{"issue":"Pt 1","key":"4161_CR279","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/bj3280179","volume":"328","author":"A Asano","year":"1997","unstructured":"A. Asano, M. Morimatsu, H. Nikami, T. Yoshida, M. Saito, Adrenergic activation of vascular endothelial growth factor mRNA expression in rat brown adipose tissue: implication in cold-induced angiogenesis. Biochem. J. 328(Pt 1), 179\u2013183 (1997)","journal-title":"Biochem. J."},{"issue":"1","key":"4161_CR280","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1124\/jpet.107.134528","volume":"326","author":"X Liu","year":"2008","unstructured":"X. Liu, W.K. Wu, L. Yu, Z.J. Li, J.J. Sung, S.T. Zhang et al. Epidermal growth factor-induced esophageal cancer cell proliferation requires transactivation of beta-adrenoceptors. J. Pharmacol. Exp. Ther. 326(1), 69\u201375 (2008)","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"4161_CR281","first-page":"353","volume":"1","author":"A Xanthopoulos","year":"2021","unstructured":"A. Xanthopoulos, I. Daskalopoulou, S. Frountzi, E. Papadimitriou, A systematic review on the role of adrenergic receptors in angiogenesis regulation in health and disease. Int. J. Transl. Med. 1(3), 353\u2013365 (2021)","journal-title":"Int. J. Transl. Med."},{"issue":"3","key":"4161_CR282","doi-asserted-by":"publisher","first-page":"830","DOI":"10.4143\/crt.2019.510","volume":"52","author":"J Zhou","year":"2020","unstructured":"J. Zhou, Z. Liu, L. Zhang, X. Hu, Z. Wang, H. Ni et al. Activation of beta2-adrenergic receptor promotes growth and angiogenesis in breast cancer by down-regulating PPARgamma. Cancer Res. Treat. 52(3), 830\u2013847 (2020)","journal-title":"Cancer Res. Treat."},{"key":"4161_CR283","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbi.2016.06.011","volume":"57","author":"A Chang","year":"2016","unstructured":"A. Chang, C.P. Le, A.K. Walker, S.J. Creed, C.K. Pon, S. Albold et al. beta2-Adrenoceptors on tumor cells play a critical role in stress-enhanced metastasis in a mouse model of breast cancer. Brain Behav. Immun. 57, 106\u2013115 (2016)","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"4161_CR284","doi-asserted-by":"publisher","first-page":"e19246","DOI":"10.1371\/journal.pone.0019246","volume":"6","author":"S Inbar","year":"2011","unstructured":"S. Inbar, E. Neeman, R. Avraham, M. Benish, E. Rosenne, S. Ben-Eliyahu, Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity. PLoS One 6(4), e19246 (2011)","journal-title":"PLoS One"},{"issue":"3","key":"4161_CR285","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0006-2952(00)00544-X","volume":"61","author":"A Kondo","year":"2001","unstructured":"A. Kondo, M. Mogi, Y. Koshihara, A. Togari, Signal transduction system for interleukin-6 and interleukin-11 synthesis stimulated by epinephrine in human osteoblasts and human osteogenic sarcoma cells. Biochem. Pharmacol. 61(3), 319\u2013326 (2001)","journal-title":"Biochem. Pharmacol."},{"key":"4161_CR286","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1118637","volume":"14","author":"L Xiao","year":"2023","unstructured":"L. Xiao, X. Li, C. Fang, J. Yu, T. Chen, Neurotransmitters: promising immune modulators in the tumor microenvironment. Front. Immunol. 14, 1118637 (2023)","journal-title":"Front. Immunol."},{"key":"4161_CR287","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/B978-0-12-384921-2.00006-9","volume":"67","author":"LA Grisanti","year":"2011","unstructured":"L.A. Grisanti, D.M. Perez, J.E. Porter, Modulation of immune cell function by alpha(1)-adrenergic receptor activation. Curr. Top. Membr. 67, 113\u2013138 (2011)","journal-title":"Curr. Top. Membr."},{"key":"4161_CR288","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/919256","volume":"2014","author":"H Tomiyama","year":"2014","unstructured":"H. Tomiyama, A. Yamashina, Beta-blockers in the management of hypertension and\/or chronic kidney disease. Int. J. Hypertens. 2014, 919256 (2014)","journal-title":"Int. J. Hypertens."},{"key":"4161_CR289","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104587","volume":"151","author":"C Fumagalli","year":"2020","unstructured":"C. Fumagalli, N. Maurizi, N. Marchionni, D. Fornasari, beta-blockers: their new life from hypertension to cancer and migraine. Pharmacol. Res. 151, 104587 (2020)","journal-title":"Pharmacol. Res."},{"issue":"6","key":"4161_CR290","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3390\/ph13060105","volume":"13","author":"R Peixoto","year":"2020","unstructured":"R. Peixoto, M.L. Pereira, M. Oliveira, Beta-blockers and cancer: where are we? Pharmaceuticals 13(6), 105 (2020)","journal-title":"Pharmaceuticals"},{"issue":"21","key":"4161_CR291","doi-asserted-by":"publisher","first-page":"7958","DOI":"10.3390\/ijms21217958","volume":"21","author":"B Mravec","year":"2020","unstructured":"B. Mravec, L. Horvathova, L. Hunakova, Neurobiology of cancer: the role of beta-adrenergic receptor signaling in various tumor environments. Int. J. Mol. Sci. 21(21), 7958 (2020)","journal-title":"Int. J. Mol. Sci."},{"key":"4161_CR292","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.phrs.2017.07.013","volume":"124","author":"L Sleire","year":"2017","unstructured":"L. Sleire, H.E. Forde, I.A. Netland, L. Leiss, B.S. Skeie, P.O. Enger, Drug repurposing in cancer. Pharmacol. Res. 124, 74\u201391 (2017)","journal-title":"Pharmacol. Res."},{"issue":"1","key":"4161_CR293","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4509-0","volume":"18","author":"JM Knight","year":"2018","unstructured":"J.M. Knight, S.A. Kerswill, P. Hari, S.W. Cole, B.R. Logan, A. D\u2019Souza et al. Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation. BMC Cancer 18(1), 593 (2018)","journal-title":"BMC Cancer"},{"issue":"2","key":"4161_CR294","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10549-024-07358-y","volume":"207","author":"C Strell","year":"2024","unstructured":"C. Strell, D.R. Smith, A. Valachis, H. Woldeyesus, C. Wadsten, P. Micke et al. Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study. Breast Cancer Res. Treat. 207(2), 293\u2013299 (2024)","journal-title":"Breast Cancer Res. Treat."},{"issue":"6","key":"4161_CR295","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00228-024-03668-8","volume":"80","author":"M Korkmaz","year":"2024","unstructured":"M. Korkmaz, M.K. Eryilmaz, M.Z. Kocak, M.M. Er, E. Hendem, A. Demirkiran et al. The effect of concomitant beta-blocker use on survival in patients with metastatic renal cell carcinoma treated with a vascular endothelial growth factor receptor inhibitors in the first line. Eur. J. Clin. Pharmacol. 80(6), 941\u2013947 (2024)","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"4161_CR296","volume":"16","author":"A Duarte Mendes","year":"2024","unstructured":"A. Duarte Mendes, A.R. Freitas, R. Vicente, R. Ferreira, T. Martins, M.J. Ramos et al. Beta-adrenergic blockade in advanced non-small cell lung cancer patients receiving immunotherapy: a multicentric study. Cureus 16(1), e52194 (2024)","journal-title":"Cureus"},{"key":"4161_CR297","unstructured":"S. Gopal, P. Mandiga, Nadolol. In: StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL), 2024). Available from: https:\/\/www.ncbi.nlm.nih.gov\/sites\/books\/NBK545189\/"},{"issue":"1","key":"4161_CR298","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF00546720","volume":"26","author":"M Schafer-Korting","year":"1984","unstructured":"M. Schafer-Korting, N. Bach, H. Knauf, E. Mutschler, Pharmacokinetics of nadolol in healthy subjects. Eur. J. Clin. Pharmacol. 26(1), 125\u2013127 (1984)","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"4161_CR299","doi-asserted-by":"publisher","unstructured":"W.G. Lee, R. Murphy, J.L. McCall, E.J. Gane, M. Soop, A. Tura, et al. Nadolol reduces insulin sensitivity in liver cirrhosis: a randomized double-blind crossover trial. Diabetes Metab Res Rev. 33(3) (2017). https:\/\/doi.org\/10.1002\/dmrr.2859","DOI":"10.1002\/dmrr.2859"},{"issue":"1","key":"4161_CR300","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bja.2018.03.024","volume":"121","author":"A Yap","year":"2018","unstructured":"A. Yap, M.A. Lopez-Olivo, J. Dubowitz, G. Pratt, J. Hiller, V. Gottumukkala et al. Effect of beta-blockers on cancer recurrence and survival: a meta-analysis of epidemiological and perioperative studies. Br. J. Anaesth. 121(1), 45\u201357 (2018)","journal-title":"Br. J. Anaesth."},{"issue":"18","key":"4161_CR301","doi-asserted-by":"publisher","first-page":"7042","DOI":"10.1158\/0008-5472.CAN-10-0522","volume":"70","author":"EK Sloan","year":"2010","unstructured":"E.K. Sloan, S.J. Priceman, B.F. Cox, S. Yu, M.A. Pimentel, V. Tangkanangnukul et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 70(18), 7042\u20137052 (2010)","journal-title":"Cancer Res."},{"issue":"10","key":"4161_CR302","doi-asserted-by":"publisher","first-page":"794 e11","DOI":"10.1016\/j.urolonc.2020.03.024","volume":"38","author":"AH Zahalka","year":"2020","unstructured":"A.H. Zahalka, E. Fram, W. Lin, L. Mohn, P.S. Frenette, I. Agalliu et al. Use of beta-blocker types and risk of incident prostate cancer in a multiethnic population. Urol. Oncol. 38(10), 794 e11\u2013e16 (2020)","journal-title":"Urol. Oncol."},{"key":"4161_CR303","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104326","volume":"147","author":"K Regulska","year":"2019","unstructured":"K. Regulska, M. Regulski, B. Karolak, M. Michalak, M. Murias, B. Stanisz, Beyond the boundaries of cardiology: still untapped anticancer properties of the cardiovascular system-related drugs. Pharmacol. Res. 147, 104326 (2019)","journal-title":"Pharmacol. Res."},{"key":"4161_CR304","unstructured":"S. Singh, C.V. Preuss, Carvedilol. In: StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL), 2024). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534868\/"},{"issue":"7","key":"4161_CR305","first-page":"1627","volume":"58","author":"BT Vanderhoff","year":"1998","unstructured":"B.T. Vanderhoff, H.M. Ruppel, P.B. Amsterdam, Carvedilol: the new role of beta blockers in congestive heart failure. Am. Fam. Physician 58(7), 1627\u20131634 (1998). 41-2","journal-title":"Am. Fam. Physician"},{"issue":"5","key":"4161_CR306","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2165\/00003088-199426050-00002","volume":"26","author":"T Morgan","year":"1994","unstructured":"T. Morgan, Clinical pharmacokinetics and pharmacodynamics of carvedilol. Clin. Pharmacokinet. 26(5), 335\u2013346 (1994)","journal-title":"Clin. Pharmacokinet."},{"issue":"8","key":"4161_CR307","first-page":"970","volume":"25","author":"HG Oldham","year":"1997","unstructured":"H.G. Oldham, S.E. Clarke, In vitro identification of the human cytochrome P450 enzymes involved in the metabolism of R(+)- and S(-)-carvedilol. Drug. Metab. Dispos. 25(8), 970\u2013977 (1997)","journal-title":"Drug. Metab. Dispos."},{"issue":"2","key":"4161_CR308","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1248\/bpb.35.151","volume":"35","author":"Y Takekuma","year":"2012","unstructured":"Y. Takekuma, K. Yagisawa, M. Sugawara, Mutual inhibition between carvedilol enantiomers during racemate glucuronidation mediated by human liver and intestinal microsomes. Biol. Pharm. Bull. 35(2), 151\u2013163 (2012)","journal-title":"Biol. Pharm. Bull."},{"key":"4161_CR309","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejca.2021.01.029","volume":"147","author":"RD Gillis","year":"2021","unstructured":"R.D. Gillis, E. Botteri, A. Chang, A.I. Ziegler, N.C. Chung, C.K. Pon et al. Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients. Eur. J. Cancer 147, 106\u2013116 (2021)","journal-title":"Eur. J. Cancer"},{"key":"4161_CR310","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116448","volume":"465","author":"A Zidan","year":"2023","unstructured":"A. Zidan, A.A. El Saadany, G.M. El Maghraby, A.A. Abdin, S.E. Hedya, Potential cardioprotective and anticancer effects of carvedilol either free or as loaded nanoparticles with or without doxorubicin in solid Ehrlich carcinoma-bearing mice. Toxicol. Appl. Pharmacol. 465, 116448 (2023)","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"13","key":"4161_CR311","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.3390\/cancers14133097","volume":"14","author":"LS Farhoumand","year":"2022","unstructured":"L.S. Farhoumand, M. Fiorentzis, M.M. Kraemer, A. Sak, M. Stuschke, T. Rassaf et al. The adrenergic receptor antagonist carvedilol elicits anti-tumor responses in uveal melanoma 3D tumor spheroids and may serve as Co-adjuvant therapy with radiation. Cancers 14(13), 3097 (2022)","journal-title":"Cancers"},{"issue":"1","key":"4161_CR312","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1158\/1940-6207.CAPR-14-0193","volume":"8","author":"A Chang","year":"2015","unstructured":"A. Chang, S. Yeung, A. Thakkar, K.M. Huang, M.M. Liu, R.S. Kanassatega et al. Prevention of skin carcinogenesis by the beta-blocker carvedilol. Cancer Prev. Res. 8(1), 27\u201336 (2015)","journal-title":"Cancer Prev. Res."},{"key":"4161_CR313","unstructured":"J. Barnes, M. Moshirfar, Timolol. In: StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL), 2024). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK545176\/"},{"issue":"2","key":"4161_CR314","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1046\/j.1365-2125.1996.39412.x","volume":"42","author":"T Wang","year":"1996","unstructured":"T. Wang, A.J. Kaumann, M.J. Brown, (\u2013)-Timolol is a more potent antagonist of the positive inotropic effects of (\u2013)-adrenaline than of those of (\u2013)-noradrenaline in human atrium. Br. J. Clin. Pharmacol. 42(2), 217\u2013223 (1996)","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"7","key":"4161_CR315","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1124\/dmd.106.012906","volume":"35","author":"M Volotinen","year":"2007","unstructured":"M. Volotinen, M. Turpeinen, A. Tolonen, J. Uusitalo, J. Maenpaa, O. Pelkonen, Timolol metabolism in human liver microsomes is mediated principally by CYP2D6. Drug. Metab. Dispos. 35(7), 1135\u20131141 (2007)","journal-title":"Drug. Metab. Dispos."},{"issue":"2","key":"4161_CR316","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF00613822","volume":"24","author":"R Mantyla","year":"1983","unstructured":"R. Mantyla, P. Mannisto, S. Nykanen, A. Koponen, U. Lamminsivu, Pharmacokinetic interactions of timolol with vasodilating drugs, food and phenobarbitone in healthy human volunteers. Eur. J. Clin. Pharmacol. 24(2), 227\u2013230 (1983)","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"11-12","key":"4161_CR317","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/j.1552-4604.1978.tb01580.x","volume":"18","author":"T Ishizaki","year":"1978","unstructured":"T. Ishizaki, K. Tawara, Y. Oyama, H. Nakaya, Clinical pharmacologic observations on timolol. I. Disposition and effect in relation to plasma level in normal individuals. J. Clin. Pharmacol. 18(11-12), 511\u2013518 (1978)","journal-title":"J. Clin. Pharmacol."},{"issue":"2","key":"4161_CR318","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/15376516.2018.1540024","volume":"29","author":"JL Wang","year":"2019","unstructured":"J.L. Wang, C.T. Chou, W.Z. Liang, C.J. Wu, C.C. Kuo, L.J. Hao et al. Effects of timolol on Ca(2+) handling and viability in human prostate cancer cells. Toxicol. Mech. Methods 29(2), 138\u2013145 (2019)","journal-title":"Toxicol. Mech. Methods"},{"issue":"4","key":"4161_CR319","doi-asserted-by":"publisher","first-page":"330","DOI":"10.4103\/0019-5154.113997","volume":"58","author":"H Ambika","year":"2013","unstructured":"H. Ambika, C. Sujatha, Y.H. Kumar, Topical timolol: a safer alternative for complicated and un-complicated infantile hemangiomas. Indian. J. Dermatol. 58(4), 330 (2013)","journal-title":"Indian. J. Dermatol."},{"issue":"1","key":"4161_CR320","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10064-x","volume":"22","author":"M Nabi-Meybodi","year":"2022","unstructured":"M. Nabi-Meybodi, A. Sahebnasagh, Z. Hakimi, M. Shabani, A.A. Shakeri, F. Saghafi, Effects of topical timolol for the prevention of radiation-induced dermatitis in breast cancer: a pilot triple-blind, placebo-controlled trial. BMC Cancer 22(1), 1079 (2022)","journal-title":"BMC Cancer"},{"key":"4161_CR321","unstructured":"S. Priyadarshni, B.H. Curry. Nebivolol. In: StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL), 2024). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551582\/"},{"issue":"12","key":"4161_CR322","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s40265-015-0435-5","volume":"75","author":"J Fongemie","year":"2015","unstructured":"J. Fongemie, E. Felix-Getzik, A review of nebivolol pharmacology and clinical evidence. Drugs 75(12), 1349\u20131371 (2015)","journal-title":"Drugs"},{"issue":"5","key":"4161_CR323","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/00005344-198805000-00007","volume":"11","author":"A Van de Water","year":"1988","unstructured":"A. Van de Water, W. Janssens, J. Van Neuten, R. Xhonneux, J. De Cree, H. Verhaegen et al. Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist. J. Cardiovasc. Pharmacol. 11(5), 552\u2013563 (1988)","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"6","key":"4161_CR324","doi-asserted-by":"publisher","first-page":"5894","DOI":"10.3390\/ijms24065894","volume":"24","author":"LS Farhoumand","year":"2023","unstructured":"L.S. Farhoumand, H. Liu, T. Tsimpaki, U.B. Hendgen-Cotta, T. Rassaf, N.E. Bechrakis et al. Blockade of ss-adrenergic receptors by nebivolol enables tumor control potential for uveal melanoma in 3D tumor spheroids and 2D cultures. Int. J. Mol. Sci. 24(6), 5894 (2023)","journal-title":"Int. J. Mol. Sci."},{"key":"4161_CR325","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.691998","volume":"12","author":"Q Chen","year":"2021","unstructured":"Q. Chen, H. Jiang, Z. Wang, L.Y. Cai, Y.C. Jiang, L. Xie et al. Adrenergic blockade by nebivolol to suppress oral squamous cell carcinoma growth via endoplasmic reticulum stress and mitochondria dysfunction. Front. Pharmacol. 12, 691998 (2021)","journal-title":"Front. Pharmacol."},{"key":"4161_CR326","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.2147\/CMAR.S166481","volume":"10","author":"F Cochera","year":"2018","unstructured":"F. Cochera, D. Dinca, D.A. Bordejevic, I.M. Citu, A.M. Mavrea, M. Andor et al. Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer. Cancer Manag. Res. 10, 2071\u20132081 (2018)","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"4161_CR327","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17384-1","volume":"11","author":"C Nuevo-Tapioles","year":"2020","unstructured":"C. Nuevo-Tapioles, F. Santacatterina, K. Stamatakis, C. Nunez de Arenas, M. Gomez de Cedron, L. Formentini et al. Coordinate beta-adrenergic inhibition of mitochondrial activity and angiogenesis arrest tumor growth. Nat. Commun. 11(1), 3606 (2020)","journal-title":"Nat. Commun."},{"issue":"5","key":"4161_CR328","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.21873\/anticanres.16357","volume":"43","author":"YJ Kim","year":"2023","unstructured":"Y.J. Kim, S.K. Jang, G. Kim, S.E. Hong, C.S. Park, M.K. Seong et al. Nebivolol sensitizes BT-474 breast cancer cells to FGFR inhibitors. Anticancer. Res. 43(5), 1973\u20131980 (2023)","journal-title":"Anticancer. Res."},{"issue":"12","key":"4161_CR329","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.18203\/2320-6012.ijrms20195537","volume":"7","author":"JS Rudrapogu","year":"2019","unstructured":"J.S. Rudrapogu, B. Govind, A. Unnagiri, Role of nebivolol in anthracycline-induced cardiotoxicity. Int. J. Res. Med. Sci. 7(12), 4677\u20134681 (2019)","journal-title":"Int. J. Res. Med. Sci."},{"issue":"1","key":"4161_CR330","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/aian.AIAN_201_18","volume":"22","author":"AV Srinivasan","year":"2019","unstructured":"A.V. Srinivasan, Propranolol: A 50-year historical perspective. Ann. Indian. Acad. Neurol. 22(1), 21\u201326 (2019)","journal-title":"Ann. Indian. Acad. Neurol."},{"key":"4161_CR331","unstructured":"M. Shahrokhi, V. Gupta. Propranolol. In: StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL), 2023). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557801\/"},{"key":"4161_CR332","first-page":"680","volume":"10","author":"P Pantziarka","year":"2016","unstructured":"P. Pantziarka, G. Bouche, V. Sukhatme, L. Meheus, I. Rooman, V.P. Sukhatme, Repurposing drugs in oncology (ReDO)-propranolol as an anti-cancer agent. Ecancermedicalscience 10, 680 (2016)","journal-title":"Ecancermedicalscience"},{"issue":"3","key":"4161_CR333","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1208\/s12248-013-9479-1","volume":"15","author":"Y Wang","year":"2013","unstructured":"Y. Wang, Z. Wang, Z. Zuo, B. Tomlinson, B.T. Lee, M.B. Bolger et al. Clinical pharmacokinetics of buffered propranolol sublingual tablet (Promptol)-application of a new \u201cphysiologically based\u201d model to assess absorption and disposition. AAPS J. 15(3), 787\u2013796 (2013)","journal-title":"AAPS J."},{"issue":"5","key":"4161_CR334","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/j.1365-2125.1984.tb02537.x","volume":"18","author":"T Walle","year":"1984","unstructured":"T. Walle, U.K. Walle, M.J. Wilson, T.C. Fagan, T.E. Gaffney, Stereoselective ring oxidation of propranolol in man. Br. J. Clin. Pharmacol. 18(5), 741\u2013748 (1984)","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"4161_CR335","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2165\/00003088-197904020-00001","volume":"4","author":"PA Routledge","year":"1979","unstructured":"P.A. Routledge, D.G. Shand, Clinical pharmacokinetics of propranolol. Clin. Pharmacokinet. 4(2), 73\u201390 (1979)","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"4161_CR336","doi-asserted-by":"publisher","first-page":"e172908","DOI":"10.1001\/jamaoncol.2017.2908","volume":"4","author":"V De Giorgi","year":"2018","unstructured":"V. De Giorgi, M. Grazzini, S. Benemei, N. Marchionni, E. Botteri, E. Pennacchioli et al. Propranolol for off-label treatment of patients with melanoma: results from a cohort study. JAMA Oncol. 4(2), e172908 (2018)","journal-title":"JAMA Oncol."},{"issue":"8","key":"4161_CR337","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJMoa1404710","volume":"372","author":"C Leaute-Labreze","year":"2015","unstructured":"C. Leaute-Labreze, P. Hoeger, J. Mazereeuw-Hautier, L. Guibaud, E. Baselga, G. Posiunas et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N. Engl. J. Med. 372(8), 735\u2013746 (2015)","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"4161_CR338","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00210-003-0860-y","volume":"369","author":"C Hoffmann","year":"2004","unstructured":"C. Hoffmann, M.R. Leitz, S. Oberdorf-Maass, M.J. Lohse, K.N. Klotz, Comparative pharmacology of human beta-adrenergic receptor subtypes-characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch. Pharmacol. 369(2), 151\u2013159 (2004)","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"27","key":"4161_CR339","doi-asserted-by":"publisher","first-page":"e1097","DOI":"10.1097\/MD.0000000000001097","volume":"94","author":"PY Chang","year":"2015","unstructured":"P.Y. Chang, W.Y. Huang, C.L. Lin, T.C. Huang, Y.Y. Wu, J.H. Chen et al. Propranolol reduces cancer risk: a population-based cohort study. Medicine 94(27), e1097 (2015)","journal-title":"Medicine"},{"issue":"3","key":"4161_CR340","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2967\/jnumed.113.121327","volume":"55","author":"F Kang","year":"2014","unstructured":"F. Kang, W. Ma, X. Ma, Y. Shao, W. Yang, X. Chen et al. Propranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2. J. Nucl. Med. 55(3), 439\u2013445 (2014)","journal-title":"J. Nucl. Med."},{"issue":"5","key":"4161_CR341","first-page":"334","volume":"41","author":"NE Wolter","year":"2012","unstructured":"N.E. Wolter, J.K. Wolter, D.J. Enepekides, M.S. Irwin, Propranolol as a novel adjunctive treatment for head and neck squamous cell carcinoma. J. Otolaryngol. Head. Neck Surg. 41(5), 334\u2013344 (2012)","journal-title":"J. Otolaryngol. Head. Neck Surg."},{"issue":"1","key":"4161_CR342","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18324-3","volume":"12","author":"LM Solerno","year":"2022","unstructured":"L.M. Solerno, N.T. Sobol, M.F. Gottardo, C.S. Capobianco, M.R. Ferrero, L. Vasquez et al. Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy. Sci. Rep. 12(1), 15058 (2022)","journal-title":"Sci. Rep."},{"issue":"12","key":"4161_CR343","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1097\/COC.0000000000000768","volume":"43","author":"MK Farrugia","year":"2020","unstructured":"M.K. Farrugia, S.J. Ma, D.M. Mattson, L. Flaherty, E.A. Repasky, A.K. Singh, Concurrent beta-blocker use is associated with improved outcome in esophageal cancer patients who undergo chemoradiation: a retrospective matched-pair analysis. Am. J. Clin. Oncol. 43(12), 889\u2013894 (2020)","journal-title":"Am. J. Clin. Oncol."},{"issue":"5","key":"4161_CR344","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s10120-021-01184-7","volume":"24","author":"M Koh","year":"2021","unstructured":"M. Koh, T. Takahashi, Y. Kurokawa, T. Kobayashi, T. Saito, T. Ishida et al. Propranolol suppresses gastric cancer cell growth by regulating proliferation and apoptosis. Gastric Cancer 24(5), 1037\u20131049 (2021)","journal-title":"Gastric Cancer"},{"issue":"3","key":"4161_CR345","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/cpt.1894","volume":"108","author":"P Liao","year":"2020","unstructured":"P. Liao, K. Song, Z. Zhu, Z. Liu, W. Zhang, W. Li et al. Propranolol suppresses the growth of colorectal cancer through simultaneously activating autologous CD8(+) T cells and inhibiting tumor AKT\/MAPK pathway. Clin. Pharmacol. Ther. 108(3), 606\u2013615 (2020)","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"4161_CR346","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25340-9","volume":"8","author":"L Brohee","year":"2018","unstructured":"L. Brohee, O. Peulen, B. Nusgens, V. Castronovo, M. Thiry, A.C. Colige et al. Propranolol sensitizes prostate cancer cells to glucose metabolism inhibition and prevents cancer progression. Sci. Rep. 8(1), 7050 (2018)","journal-title":"Sci. Rep."},{"issue":"11","key":"4161_CR347","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3109\/13880209.2014.892513","volume":"52","author":"OD Iseri","year":"2014","unstructured":"O.D. Iseri, F.I. Sahin, Y.K. Terzi, E. Yurtcu, S.R. Erdem, F. Sarialioglu, beta-adrenoreceptor antagonists reduce cancer cell proliferation, invasion, and migration. Pharm. Biol. 52(11), 1374\u20131381 (2014)","journal-title":"Pharm. Biol."},{"issue":"114","key":"4161_CR348","first-page":"584","volume":"59","author":"X Lin","year":"2012","unstructured":"X. Lin, K. Luo, Z. Lv, J. Huang, Beta-adrenoceptor action on pancreatic cancer cell proliferation and tumor growth in mice. Hepatogastroenterology 59(114), 584\u2013588 (2012)","journal-title":"Hepatogastroenterology"},{"issue":"9","key":"4161_CR349","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1093\/carcin\/10.9.1753","volume":"10","author":"HM Schuller","year":"1989","unstructured":"H.M. Schuller, B. Cole, Regulation of cell proliferation by beta-adrenergic receptors in a human lung adenocarcinoma cell line. Carcinogenesis 10(9), 1753\u20131755 (1989)","journal-title":"Carcinogenesis"},{"key":"4161_CR350","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-72","volume":"11","author":"SL Valles","year":"2013","unstructured":"S.L. Valles, M. Benlloch, M.L. Rodriguez, S. Mena, J.A. Pellicer, M. Asensi et al. Stress hormones promote growth of B16-F10 melanoma metastases: an interleukin 6- and glutathione-dependent mechanism. J. Transl. Med. 11, 72 (2013)","journal-title":"J. Transl. Med."},{"issue":"1","key":"4161_CR351","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/MPA.0b013e318184f50c","volume":"38","author":"D Zhang","year":"2009","unstructured":"D. Zhang, Q. Ma, S. Shen, H. Hu, Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: the study of beta-adrenoceptor antagonist\u2019s anticancer effect in pancreatic cancer cell. Pancreas 38(1), 94\u2013100 (2009)","journal-title":"Pancreas"},{"issue":"4","key":"4161_CR352","first-page":"292","volume":"124","author":"MY Terzi","year":"2023","unstructured":"M.Y. Terzi, M. Urhan-Kucuk, Anti-proliferative effects of beta-blocker propranolol on human lung cancer and noncancer cells. Bratisl. Lek. Listy 124(4), 292\u2013303 (2023)","journal-title":"Bratisl. Lek. Listy"},{"key":"4161_CR353","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3389\/fonc.2019.01491","volume":"9","author":"Z Wang","year":"2019","unstructured":"Z. Wang, Y. Zhao, Z. An, W. Li, Molecular links between angiogenesis and neuroendocrine phenotypes in prostate cancer progression. Front. Oncol. 9, 1491 (2019)","journal-title":"Front. Oncol."},{"issue":"2","key":"4161_CR354","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/jid.2014.373","volume":"135","author":"LJ Wrobel","year":"2015","unstructured":"L.J. Wrobel, F.A. Le Gal, Inhibition of human melanoma growth by a non-cardioselective beta-blocker. J. Invest. Dermatol. 135(2), 525\u2013531 (2015)","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"4161_CR355","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.bj.2019.02.003","volume":"42","author":"A Montoya","year":"2019","unstructured":"A. Montoya, A. Varela-Ramirez, E. Dickerson, E. Pasquier, A. Torabi, R. Aguilera et al. The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer. Biomed. J. 42(3), 155\u2013165 (2019)","journal-title":"Biomed. J."},{"issue":"6","key":"4161_CR356","first-page":"1669","volume":"24","author":"X Liao","year":"2010","unstructured":"X. Liao, X. Che, W. Zhao, D. Zhang, T. Bi, G. Wang, The beta-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor kappaB signaling. Oncol. Rep. 24(6), 1669\u20131676 (2010)","journal-title":"Oncol. Rep."},{"issue":"42","key":"4161_CR357","doi-asserted-by":"publisher","first-page":"68314","DOI":"10.18632\/oncotarget.11599","volume":"7","author":"C Zhou","year":"2016","unstructured":"C. Zhou, X. Chen, W. Zeng, C. Peng, G. Huang, X. Li et al. Propranolol induced G0\/G1\/S phase arrest and apoptosis in melanoma cells via AKT\/MAPK pathway. Oncotarget 7(42), 68314\u201368327 (2016)","journal-title":"Oncotarget"},{"issue":"4","key":"4161_CR358","first-page":"5213","volume":"17","author":"F Wang","year":"2018","unstructured":"F. Wang, H. Liu, F. Wang, R. Xu, P. Wang, F. Tang et al. Propranolol suppresses the proliferation and induces the apoptosis of liver cancer cells. Mol. Med. Rep. 17(4), 5213\u20135221 (2018)","journal-title":"Mol. Med. Rep."},{"issue":"20","key":"4161_CR359","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.7150\/jca.46556","volume":"11","author":"S Zhao","year":"2020","unstructured":"S. Zhao, S. Fan, Y. Shi, H. Ren, H. Hong, X. Gao et al. Propranolol induced apoptosis and autophagy via the ROS\/JNK signaling pathway in human ovarian cancer. J. Cancer 11(20), 5900\u20135910 (2020)","journal-title":"J. Cancer"},{"issue":"1","key":"4161_CR360","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000332423","volume":"21","author":"D Chen","year":"2012","unstructured":"D. Chen, X. Zheng, D. Kang, B. Yan, X. Liu, Y. Gao et al. Apoptosis and expression of the Bcl-2 family of proteins and P53 in human pancreatic ductal adenocarcinoma. Med. Princ. Pract. 21(1), 68\u201373 (2012)","journal-title":"Med. Princ. Pract."},{"issue":"4","key":"4161_CR361","first-page":"366","volume":"119","author":"R De Almeida","year":"2022","unstructured":"R. De Almeida, S. McCalmon, P.K. Cabandugama, Clinical review and update on the management of thyroid storm. Mo. Med. 119(4), 366\u2013371 (2022)","journal-title":"Mo. Med."},{"issue":"2-3","key":"4161_CR362","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0014-5793(98)01627-5","volume":"442","author":"C Tonello","year":"1999","unstructured":"C. Tonello, A. Giordano, V. Cozzi, S. Cinti, M.J. Stock, M.O. Carruba et al. Role of sympathetic activity in controlling the expression of vascular endothelial growth factor in brown fat cells of lean and genetically obese rats. FEBS Lett. 442(2-3), 167\u2013172 (1999)","journal-title":"FEBS Lett."},{"issue":"8","key":"4161_CR363","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1158\/1078-0432.CCR-08-2966","volume":"15","author":"JW Lee","year":"2009","unstructured":"J.W. Lee, M.M. Shahzad, Y.G. Lin, G. Armaiz-Pena, L.S. Mangala, H.D. Han et al. Surgical stress promotes tumor growth in ovarian carcinoma. Clin. Cancer Res. 15(8), 2695\u20132702 (2009)","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"4161_CR364","doi-asserted-by":"publisher","first-page":"e979699","DOI":"10.4161\/19381980.2014.979699","volume":"6","author":"JJ Kum","year":"2014","unstructured":"J.J. Kum, Z.A. Khan, Mechanisms of propranolol action in infantile hemangioma. Dermatoendocrinol 6(1), e979699 (2014)","journal-title":"Dermatoendocrinol"},{"issue":"4","key":"4161_CR365","first-page":"223","volume":"13","author":"F Hajighasemi","year":"2009","unstructured":"F. Hajighasemi, S. Hajighasemi, Effect of propranolol on angiogenic factors in human hematopoietic cell lines in vitro. Iran. Biomed. J. 13(4), 223\u2013228 (2009)","journal-title":"Iran. Biomed. J."},{"issue":"2","key":"4161_CR366","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bbi.2008.10.005","volume":"23","author":"EV Yang","year":"2009","unstructured":"E.V. Yang, S.J. Kim, E.L. Donovan, M. Chen, A.C. Gross, J.I. Webster Marketon et al. Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav. Immun. 23(2), 267\u2013275 (2009)","journal-title":"Brain Behav. Immun."},{"issue":"21","key":"4161_CR367","doi-asserted-by":"publisher","first-page":"10357","DOI":"10.1158\/0008-5472.CAN-06-2496","volume":"66","author":"EV Yang","year":"2006","unstructured":"E.V. Yang, A.K. Sood, M. Chen, Y. Li, T.D. Eubank, C.B. Marsh et al. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res. 66(21), 10357\u201310364 (2006)","journal-title":"Cancer Res."},{"issue":"12","key":"4161_CR368","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1038\/bjc.2013.205","volume":"108","author":"E Pasquier","year":"2013","unstructured":"E. Pasquier, J. Street, C. Pouchy, M. Carre, A.J. Gifford, J. Murray et al. beta-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma. Br. J. Cancer 108(12), 2485\u20132494 (2013)","journal-title":"Br. J. Cancer"},{"issue":"4","key":"4161_CR369","first-page":"825","volume":"22","author":"K Guo","year":"2009","unstructured":"K. Guo, Q. Ma, L. Wang, H. Hu, J. Li, D. Zhang et al. Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol. Oncol. Rep. 22(4), 825\u2013830 (2009)","journal-title":"Oncol. Rep."},{"issue":"2","key":"4161_CR370","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/ijc.20410","volume":"112","author":"K Lang","year":"2004","unstructured":"K. Lang, T.L. Drell 4th, A. Lindecke, B. Niggemann, C. Kaltschmidt, K.S. Zaenker et al. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int. J. Cancer 112(2), 231\u2013238 (2004)","journal-title":"Int. J. Cancer"},{"issue":"3","key":"4161_CR371","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3892\/etm.2015.2650","volume":"10","author":"S Wu","year":"2015","unstructured":"S. Wu, B. Wang, L. Chen, S. Xiong, F. Zhuang, X. Huang et al. Clinical efficacy of propranolol in the treatment of hemangioma and changes in serum VEGF, bFGF and MMP-9. Exp. Ther. Med. 10(3), 1079\u20131083 (2015)","journal-title":"Exp. Ther. Med."},{"key":"4161_CR372","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2147\/OTT.S14503","volume":"3","author":"B Annabi","year":"2010","unstructured":"B. Annabi, E. Vaillancourt-Jean, A.G. Weil, R. Beliveau, Pharmacological targeting of beta-adrenergic receptor functions abrogates NF-kappaB signaling and MMP-9 secretion in medulloblastoma cells. Onco Targets Ther. 3, 219\u2013226 (2010)","journal-title":"Onco Targets Ther."},{"issue":"3","key":"4161_CR373","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/labinvest.2012.175","volume":"93","author":"S Moretti","year":"2013","unstructured":"S. Moretti, D. Massi, V. Farini, G. Baroni, M. Parri, S. Innocenti et al. beta-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines. Lab. Invest. 93(3), 279\u2013290 (2013)","journal-title":"Lab. Invest."},{"issue":"2","key":"4161_CR374","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1158\/1078-0432.CCR-05-1698","volume":"12","author":"AK Sood","year":"2006","unstructured":"A.K. Sood, R. Bhatty, A.A. Kamat, C.N. Landen, L. Han, P.H. Thaker et al. Stress hormone-mediated invasion of ovarian cancer cells. Clin. Cancer Res. 12(2), 369\u2013375 (2006)","journal-title":"Clin. Cancer Res."},{"issue":"22","key":"4161_CR375","doi-asserted-by":"publisher","first-page":"5626","DOI":"10.3390\/ijms20225626","volume":"20","author":"P Avril","year":"2019","unstructured":"P. Avril, L. Vidal, S. Barille-Nion, L.R. Le Nail, F. Redini, P. Layrolle et al. Epinephrine infiltration of adipose tissue impacts MCF7 breast cancer cells and total lipid content. Int. J. Mol. Sci. 20(22), 5626 (2019)","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"4161_CR376","doi-asserted-by":"publisher","first-page":"4858","DOI":"10.3390\/cancers13194858","volume":"13","author":"S Murugan","year":"2021","unstructured":"S. Murugan, B. Rousseau, D.K. Sarkar, Beta 2 adrenergic receptor antagonist propranolol and opioidergic receptor antagonist naltrexone produce synergistic effects on breast cancer growth prevention by acting on cancer cells and immune environment in a preclinical model of breast cancer. Cancers 13(19), 4858 (2021)","journal-title":"Cancers"},{"issue":"1","key":"4161_CR377","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-021-00755-6","volume":"19","author":"M Archer","year":"2021","unstructured":"M. Archer, N. Dogra, Z. Dovey, T. Ganta, H.S. Jang, J.A. Khusid et al. Role of alpha- and beta-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease. Cell Commun. Signal. 19(1), 78 (2021)","journal-title":"Cell Commun. Signal."},{"issue":"6","key":"4161_CR378","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101076","volume":"14","author":"A Vankerckhoven","year":"2021","unstructured":"A. Vankerckhoven, T. Baert, M. Riva, C. De Bruyn, G. Thirion, K. Vandenbrande et al. Type of chemotherapy has substantial effects on the immune system in ovarian cancer. Transl. Oncol. 14(6), 101076 (2021)","journal-title":"Transl. Oncol."},{"issue":"10","key":"4161_CR379","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/0024-3205(90)90600-V","volume":"47","author":"H Teshima","year":"1990","unstructured":"H. Teshima, H. Sogawa, H. Kihara, C. Kubo, K. Mori, T. Nakagawa, Prevention of immunosuppression in stressed mice by neurotropin(NSP). Life Sci. 47(10), 869\u2013876 (1990)","journal-title":"Life Sci."},{"key":"4161_CR380","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1289\/ehp.824321","volume":"43","author":"L Rasmussen","year":"1982","unstructured":"L. Rasmussen, A. Arvin, Chemotherapy-induced immunosuppression. Env. Health Perspect. 43, 21\u201325 (1982)","journal-title":"Env. Health Perspect."},{"issue":"9","key":"4161_CR381","doi-asserted-by":"publisher","first-page":"e74497","DOI":"10.1371\/journal.pone.0074497","volume":"8","author":"J Jin","year":"2013","unstructured":"J. Jin, X. Wang, Q. Wang, X. Guo, J. Cao, X. Zhang et al. Chronic psychological stress induces the accumulation of myeloid-derived suppressor cells in mice. PLoS One 8(9), e74497 (2013)","journal-title":"PLoS One"},{"issue":"1","key":"4161_CR382","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1365-2249.2005.02672.x","volume":"139","author":"O Kanemi","year":"2005","unstructured":"O. Kanemi, X. Zhang, Y. Sakamoto, M. Ebina, R. Nagatomi, Acute stress reduces intraparenchymal lung natural killer cells via beta-adrenergic stimulation. Clin. Exp. Immunol. 139(1), 25\u201334 (2005)","journal-title":"Clin. Exp. Immunol."},{"key":"4161_CR383","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2023.02.011","volume":"110","author":"M Falcinelli","year":"2023","unstructured":"M. Falcinelli, G. Al-Hity, S. Baron, M. Mampay, M.C. Allen, M. Samuels et al. Propranolol reduces IFN-gamma driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer. Brain Behav. Immun. 110, 1\u201312 (2023)","journal-title":"Brain Behav. Immun."},{"issue":"47","key":"4161_CR384","doi-asserted-by":"publisher","first-page":"77825","DOI":"10.18632\/oncotarget.12833","volume":"7","author":"L Jean Wrobel","year":"2016","unstructured":"L. Jean Wrobel, L. Bod, R. Lengagne, M. Kato, A. Prevost-Blondel, F.A. Le Gal, Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma. Oncotarget 7(47), 77825\u201377837 (2016)","journal-title":"Oncotarget"},{"issue":"4","key":"4161_CR385","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/bjc.1984.207","volume":"50","author":"A Ramu","year":"1984","unstructured":"A. Ramu, R. Spanier, H. Rahamimoff, Z. Fuks, Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells. Br. J. Cancer 50(4), 501\u2013507 (1984)","journal-title":"Br. J. Cancer"},{"issue":"4","key":"4161_CR386","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/S0026-895X(25)13330-0","volume":"33","author":"JM Zamora","year":"1988","unstructured":"J.M. Zamora, H.L. Pearce, W.T. Beck, Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol. Pharmacol. 33(4), 454\u2013462 (1988)","journal-title":"Mol. Pharmacol."},{"key":"4161_CR387","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.614288","volume":"10","author":"J Saha","year":"2020","unstructured":"J. Saha, J.H. Kim, C.N. Amaya, C. Witcher, A. Khammanivong, D.M. Korpela et al. Propranolol sensitizes vascular sarcoma cells to doxorubicin by altering lysosomal drug sequestration and drug efflux. Front. Oncol. 10, 614288 (2020)","journal-title":"Front. Oncol."},{"key":"4161_CR388","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/JEP.S146211","volume":"10","author":"MJ Wagner","year":"2018","unstructured":"M.J. Wagner, L.D. Cranmer, E.T. Loggers, S.M. Pollack, Propranolol for the treatment of vascular sarcomas. J. Exp. Pharmacol. 10, 51\u201358 (2018)","journal-title":"J. Exp. Pharmacol."},{"issue":"5","key":"4161_CR389","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1161\/01.RES.78.5.737","volume":"78","author":"RM Graham","year":"1996","unstructured":"R.M. Graham, D.M. Perez, J. Hwa, M.T. Piascik, \u03b11-adrenergic receptor subtypes: molecular structure, function, and signaling. Circ. Res. 78(5), 737\u2013749 (1996)","journal-title":"Circ. Res."},{"key":"4161_CR390","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.581098","volume":"11","author":"DM Perez","year":"2020","unstructured":"D.M. Perez, alpha(1)-adrenergic receptors in neurotransmission, synaptic plasticity, and cognition. Front. Pharmacol. 11, 581098 (2020)","journal-title":"Front. Pharmacol."},{"key":"4161_CR391","unstructured":"B.N.Taylor, M. Cassagnol. Alpha-Adrenergic Receptors. In: StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL), 2023)."},{"issue":"1","key":"4161_CR392","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2344\/0003-3006-62.1.31","volume":"62","author":"JA Giovannitti Jr","year":"2015","unstructured":"J.A. Giovannitti Jr, S.M. Thoms, J.J. Crawford, Alpha-2 adrenergic receptor agonists: a review of current clinical applications. Anesth. Prog. 62(1), 31\u201339 (2015)","journal-title":"Anesth. Prog."},{"key":"4161_CR393","unstructured":"J. N\u00e4sman. Alpha-Adrenergic Receptors. In: StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL), 2023)"},{"key":"4161_CR394","unstructured":"S. Alhayek, C.V. Preuss. Beta 1 Receptors. In: StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL), 2023). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532904\/"},{"issue":"7203","key":"4161_CR395","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nature07101","volume":"454","author":"T Warne","year":"2008","unstructured":"T. Warne, M.J. Serrano-Vega, J.G. Baker, R. Moukhametzianov, P.C. Edwards, R. Henderson et al. Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 454(7203), 486\u2013491 (2008)","journal-title":"Nature"},{"issue":"1","key":"4161_CR396","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31823-1","volume":"13","author":"M Su","year":"2022","unstructured":"M. Su, N. Paknejad, L. Zhu, J. Wang, H.N. Do, Y. Miao et al. Structures of beta(1)-adrenergic receptor in complex with Gs and ligands of different efficacies. Nat. Commun. 13(1), 4095 (2022)","journal-title":"Nat. Commun."},{"issue":"3","key":"4161_CR397","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1161\/CIRCHEARTFAILURE.112.966895","volume":"5","author":"G Rengo","year":"2012","unstructured":"G. Rengo, P. Perrone-Filardi, G.D. Femminella, D. Liccardo, C. Zincarelli, C. de Lucia et al. Targeting the beta-adrenergic receptor system through G-protein-coupled receptor kinase 2: a new paradigm for therapy and prognostic evaluation in heart failure: from bench to bedside. Circ. Heart Fail. 5(3), 385\u2013391 (2012)","journal-title":"Circ. Heart Fail."},{"key":"4161_CR398","unstructured":"N.R. Abosamak, M.H. Shahin. Beta2 Receptor Agonists and Antagonists. In: StatPearls [Internet]. (StatPearls Publishing, Treasure Island (FL), 2023). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559069\/"},{"issue":"21","key":"4161_CR399","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.4161\/cc.10.21.18042","volume":"10","author":"NT Vasudevan","year":"2011","unstructured":"N.T. Vasudevan, M.L. Mohan, S.K. Goswami, S.V. Naga Prasad, Regulation of beta-adrenergic receptor function: an emphasis on receptor resensitization. Cell Cycle 10(21), 3684\u20133691 (2011)","journal-title":"Cell Cycle"},{"issue":"37","key":"4161_CR400","doi-asserted-by":"publisher","first-page":"23096","DOI":"10.1073\/pnas.2009786117","volume":"117","author":"X Ma","year":"2020","unstructured":"X. Ma, Y. Hu, H. Batebi, J. Heng, J. Xu, X. Liu et al. Analysis of beta(2)AR-G(s) and beta(2)AR-G(i) complex formation by NMR spectroscopy. Proc. Natl Acad. Sci. 117(37), 23096\u201323105 (2020)","journal-title":"Proc. Natl Acad. Sci."},{"issue":"10","key":"4161_CR401","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2215916120","volume":"120","author":"Y Han","year":"2023","unstructured":"Y. Han, J.R.D. Dawson, K.R. DeMarco, K.C. Rouen, S. Bekker, V. Yarov-Yarovoy et al. Elucidation of a dynamic interplay between a beta-2 adrenergic receptor, its agonist, and stimulatory G protein. Proc. Natl Acad. Sci. 120(10), e2215916120 (2023)","journal-title":"Proc. Natl Acad. Sci."},{"issue":"1","key":"4161_CR402","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37233-1","volume":"14","author":"J Heng","year":"2023","unstructured":"J. Heng, Y. Hu, G. Perez-Hernandez, A. Inoue, J. Zhao, X. Ma et al. Function and dynamics of the intrinsically disordered carboxyl terminus of beta2 adrenergic receptor. Nat. Commun. 14(1), 2005 (2023)","journal-title":"Nat. Commun."},{"key":"4161_CR403","doi-asserted-by":"crossref","unstructured":"G. Schena, M.J. Caplan, Everything you always wanted to know about beta(3)-AR * (* But Were Afraid to Ask). Cells. 8(4), 357 (2019).","DOI":"10.3390\/cells8040357"},{"issue":"11","key":"4161_CR404","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.3390\/ijms22115721","volume":"22","author":"E Haji","year":"2021","unstructured":"E. Haji, S. Al Mahri, Y. Aloraij, S.S. Malik, S. Mohammad, Functional characterization of the obesity-linked variant of the beta(3)-adrenergic receptor. Int. J. Mol. Sci. 22(11), 5721 (2021)","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"4161_CR405","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1017\/S1751731110001564","volume":"5","author":"JL Wu","year":"2011","unstructured":"J.L. Wu, W.Z. Liu, J.H. Liu, L.Y. Qiao, Y.N. Yuan, Distribution and quantification of beta-3 adrenergic receptor in tissues of sheep. Animal 5(1), 88\u201393 (2011)","journal-title":"Animal"},{"issue":"2","key":"4161_CR406","first-page":"169","volume":"50","author":"OA Coman","year":"2009","unstructured":"O.A. Coman, H. Paunescu, I. Ghita, L. Coman, A. Badararu, I. Fulga, Beta 3 adrenergic receptors: molecular, histological, functional and pharmacological approaches. Rom. J. Morphol. Embryol. 50(2), 169\u2013179 (2009)","journal-title":"Rom. J. Morphol. Embryol."},{"issue":"2","key":"4161_CR407","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04603-4","volume":"13","author":"Z Zhou","year":"2022","unstructured":"Z. Zhou, J. Zhan, Q. Luo, X. Hou, S. Wang, D. Xiao et al. ADRB3 induces mobilization and inhibits differentiation of both breast cancer cells and myeloid-derived suppressor cells. Cell Death Dis. 13(2), 141 (2022)","journal-title":"Cell Death Dis."},{"issue":"2","key":"4161_CR408","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s10549-010-0822-2","volume":"125","author":"M Shi","year":"2011","unstructured":"M. Shi, D. Liu, H. Duan, L. Qian, L. Wang, L. Niu et al. The beta2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells. Breast Cancer Res. Treat. 125(2), 351\u2013362 (2011)","journal-title":"Breast Cancer Res. Treat."},{"issue":"8","key":"4161_CR409","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1364\/BOE.10.004115","volume":"10","author":"I Agranovich","year":"2019","unstructured":"I. Agranovich, E. Borisova, N. Navolokin, A. Bucharskaya, G. Maslyakova, A. Shirokov et al. Phenomenon of atypical vascular effects of epinephrine and an increase of photodynamic response by nitroglycerin in rats with colon adenocarcinoma: adrenergic and nitrergic mechanisms and novel applied aspects. Biomed. Opt. Express 10(8), 4115\u20134125 (2019)","journal-title":"Biomed. Opt. Express"},{"issue":"11","key":"4161_CR410","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s00262-020-02627-3","volume":"69","author":"M Zheng","year":"2020","unstructured":"M. Zheng, Z. Zhou, X. Tian, D. Xiao, X. Hou, Z. Xie et al. ADRB3 expression in tumor cells is a poor prognostic factor and promotes proliferation in non-small cell lung carcinoma. Cancer Immunol. Immunother. 69(11), 2345\u20132355 (2020)","journal-title":"Cancer Immunol. Immunother."},{"key":"4161_CR411","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.radonc.2020.02.004","volume":"146","author":"Y Zhang","year":"2020","unstructured":"Y. Zhang, P. Zanos, I.L. Jackson, X. Zhang, X. Zhu, T. Gould et al. Psychological stress enhances tumor growth and diminishes radiation response in preclinical model of lung cancer. Radiother. Oncol. 146, 126\u2013135 (2020)","journal-title":"Radiother. Oncol."},{"issue":"12","key":"4161_CR412","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1002\/ijc.29646","volume":"137","author":"J Banerjee","year":"2015","unstructured":"J. Banerjee, A.M. Papu John, H.M. Schuller, Regulation of nonsmall-cell lung cancer stem cell like cells by neurotransmitters and opioid peptides. Int. J. Cancer 137(12), 2815\u20132824 (2015)","journal-title":"Int. J. Cancer"},{"issue":"6","key":"4161_CR413","first-page":"1197","volume":"10","author":"T Bando","year":"1997","unstructured":"T. Bando, M. Fujimura, K. Kasahara, K. Shibata, H. Shirasaki, U. Heki et al. Stimulation of beta-adrenoceptor enhances sensitivity to cisplatin in non-small cell lung cancer cell lines. Int. J. Oncol. 10(6), 1197\u20131201 (1997)","journal-title":"Int. J. Oncol."},{"issue":"21","key":"4161_CR414","doi-asserted-by":"publisher","first-page":"12829","DOI":"10.3390\/ijms232112829","volume":"23","author":"R Ray","year":"2022","unstructured":"R. Ray, H. Al Khashali, B. Haddad, J. Wareham, K.L. Coleman, D. Alomari et al. Regulation of cisplatin resistance in lung cancer cells by nicotine, BDNF, and a beta-adrenergic receptor blocker. Int. J. Mol. Sci. 23(21), 12829 (2022)","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"4161_CR415","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1002\/jcb.20892","volume":"98","author":"S Naviglio","year":"2006","unstructured":"S. Naviglio, A. Spina, E. Chiosi, A. Fusco, F. Illiano, M. Pagano et al. Inorganic phosphate inhibits growth of human osteosarcoma U2OS cells via adenylate cyclase\/cAMP pathway. J. Cell Biochem. 98(6), 1584\u20131596 (2006)","journal-title":"J. Cell Biochem."},{"issue":"5","key":"4161_CR416","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1172\/JCI40802","volume":"120","author":"AK Sood","year":"2010","unstructured":"A.K. Sood, G.N. Armaiz-Pena, J. Halder, A.M. Nick, R.L. Stone, W. Hu et al. Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. J. Clin. Invest. 120(5), 1515\u20131523 (2010)","journal-title":"J. Clin. Invest."},{"issue":"8","key":"4161_CR417","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.4049\/jimmunol.1501677","volume":"196","author":"L Zhou","year":"2016","unstructured":"L. Zhou, Y. Li, X. Li, G. Chen, H. Liang, Y. Wu et al. Propranolol attenuates surgical stress-induced elevation of the regulatory T cell response in patients undergoing radical mastectomy. J. Immunol. 196(8), 3460\u20133469 (2016)","journal-title":"J. Immunol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04161-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04161-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04161-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T20:02:12Z","timestamp":1747080132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04161-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":417,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["4161"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04161-7","relation":{},"ISSN":["1559-0100"],"issn-type":[{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"10 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}